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ASSOCIATIVE MEMORY FUNCTION IN THE AGING BRAIN
1.1 Public health significance of
understanding Alzheimer’s disease

studying normal

aging: Implications

towards

Advances in medicine and health care are shifting the demographics worldwide, with the
number of individuals over 65 years of age in the US projected to triple from the year 2000 to
2060 (www.census.gov). Longevity, however, comes with a risk of increased occurrence of agerelated cognitive deficits imparting tremendous societal, economic, and healthcare burden on
patients and their families. About 5.4 million older Americans have cognitive impairments
without full-blown dementia, and such impairments affect the quality of life. Aging is also
associated with a dramatic rise in the incidence of neurodegenerative disorders such as
Alzheimer disease (AD), and indeed is the primary risk factor thereof. Healthcare, financial, and
emotional burden, along with the fact that the neuropathology of AD precedes cognitive changes
by several years, make it crucial to identify biomarkers of very early disease progression
(Rupsingh, Borrie, Smith, Wells, & Bartha, 2011) to help make timely intervention possible. The
good news in medicine is that early detection often means early intervention. Clinical trials for
AD have focused on drugs targeting cognitive symptoms of the disease, as well as classical AD
pathology such as amyloid beta plaques and tau tangles as seen on MRIs. AD diagnosis has also
always been based primarily on the detection of these two pathological signatures. However, the
amyloid hypothesis of AD has been unsuccessful in producing consistent data on disease
prognosis (Makin, 2018), hence, also failing to contribute to the design of effective interventions.
Most interventions targeting amyloid plaques have been futile in their attempt to improve
cognitive performance and nor have they slowed down the progression of dementia. It is thus,
important to target an earlier point in time that precedes the occurrence of amyloid and tau.
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While age-related dementia and AD are important concerns, most people undergo
‘normal aging’ or ‘healthy aging’ and do not go on to develop dementia. Although cognitive
decline is a key manifestation of AD, it is part of normal aging as well. An understanding of the
aging process and age differences that underlie cognitive dysfunction are important to be able to
identify deviations from normal to pathological aging and to eventually design effective
interventions to slow them. This dissertation focuses on an approach towards identifying a
plausible functional biomarker of age-related differences in cognition, specifically in associative
learning and memory performance. The present study is significant as it contributes, not only to
the understanding of age effects on cognition but can also be applied to track cognitive changes
in aging and impending dementia.
1.1.1 Associative memory in aging
Memory loss is one of the earliest cognitive impairments observed in normal aging as
well as in dementia and is also the one that has received the most attention. However, an
intriguing feature of age effects on memory is their variability. Memory is not a single construct
but is instead of several types that are differentially vulnerable to the effects of age. Of those,
decline in episodic memory (EM) is a hallmark feature of cognitive aging (Rönnlund, Nyberg,
Backman, & Nilsson, 2005; Verhaeghen & Marcoen, 1993) and, at its extremes, a defining
symptom of AD (Morris & Kopelman, 1986). EM amounts to recollecting experiences that occur
in time and space (Rolls, Stringer, & Trappenberg, 2002) and frequently relies on establishing
associations between two unrelated stimuli where one stimulus can invoke the other during
recall. The ability to use contextual cues linked to the target items for facilitating the retrieval of
the latter is a general feature of EM and has been described as environmental support (Craik,
1986). The two-component framework of EM includes an associative component representing
the binding processes that combine features of episodes (i.e. the stimuli) to create coherent
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representations; and a strategy component made up of cognitive processes that support and
regulate memory functions (Shing, Werkle-Bergner, Li, & Lindenberger, 2008). Memory
function involves, besides perception of the stimulus; encoding, consolidation, maintenance, and
retrieval (Tulving, 1983). Memory encoding involves the pairing of distinct memoranda such as
faces with names, objects with locations, or any other contextual features. Making associations
between previously unrelated memoranda helps us navigate the world.
Extant literature suggests that in most cases, older adults’ EM decline is attributed to
impairment in the associative component (Naveh-Benjamin & Mayr, 2018). Older adults are
differentially impaired in retrieving associations rather than individual items and show
disproportionately lower recall for contextual cues that could have been useful in facilitating
recall (Old & Naveh-Benjamin, 2008; Spencer & Raz, 1995). This differential impairment has
led to the formulation of the associative deficit hypothesis (ADH), which states that impaired
binding of individual units of information into associations is the core reason for age-related
memory decline (Naveh-Benjamin, 2000). The ADH has been confirmed in paired-associate
memory studies utilizing tasks such as learning associations between word-pairs, words-pictures,
and faces-names (Bender, Naveh-Benjamin, Amann, & Raz, 2017; Naveh-Benjamin, 2000).
Some reports have suggested that deficiencies in associative encoding, more than retrieval, play
a larger role in associative and episodic memory dysfunction in the elderly (Friedman, Nessler,
& Johnson, 2007; Tromp, Dufour, Lithfous, Pebayle, & Despres, 2015). With the ADH gaining
wide acceptance, it still remains unclear what brain mechanisms are responsible for the
emergence of this age-related deficit.
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1.2 Hippocampal and glutamatergic involvement in associative memory
1.2.1 Role of the hippocampus
Memory function has been linked to the brain’s integrity (Ribot, 1882)., with the main
brain regions involved in associative encoding and retrieval being the medial temporal lobe
(MTL), the prefrontal cortex (PFC), the lateral parietal cortex, and the dorsal anterior cingulate
cortex (dACC) (Davachi, 2006; Woodcock, White, & Diwadkar, 2015). However, since the
seminal study of the patient H.M. (Scoville & Milner, 1957), the attention of memory researchers
has been focused on the hippocampus and surrounding circuitry (Lavenex & Amaral, 2000). The
hippocampus is critical for the binding of distinct memoranda and the formation of memory, for
temporarily storing memory of individual items and associations, and later transferring them to
the neocortex for permanent storage (Eichenbaum, 2001). The unique anatomical location of the
hippocampus facilitates the reception of inputs from the association cortices, making it the hub
of the associative memory network (Lavenex & Amaral, 2000; Ungerleider, 1995) (Binding of
Items and Contexts model, BIC, (R. A. Diana, Yonelinas, & Ranganath, 2007)). For example,
the ventral and dorsal visual processing streams (‘what’ and ‘where’ pathways) carrying
information about the identity and spatial location of an object, respectively, relay it to the lateral
and medial entorhinal cortices via the perirhinal and the parahippocampal cortices, respectively
(Lavenex & Amaral, 2000), to finally converge at the level of the hippocampus.
Studies on human brain lesions (Burgess, Maguire, & O'Keefe, 2002; Zola-Morgan,
Squire, & Amaral, 1986) and animal models (Eichenbaum, Yonelinas, & Ranganath, 2007;
Suzuki, 2007) support the view of the hippocampus and connected MTL circuitry as the most
important neural substrates of EM in general and associative memory, in particular. Sustained
hippocampal activity is required for encoding memories of new items as well as formation and
maintenance of associations among them (Davachi & Wagner, 2002; Piekema, Kessels, Mars,
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Petersson, & Fernandez, 2006). The importance of the hippocampus in associative memory
function is further underscored by the observation of greater hippocampal activation (evidenced
by fMRI) during the encoding of associations than of single items (Dennis et al., 2008).
With hippocampal shrinkage being a well-documented feature of normal aging (Raz &
Rodrigue, 2006) and one of the earliest foci of neurodegeneration in AD (Braak & Braak, 1995),
it stands to reason that memory declines would correlate with hippocampal structural changes.
Although there is indeed some limited support for that expectation, the hypothesized associations
remain weak and inconsistently replicated (VanPetten, 2004). It is important, also to
acknowledge, that aging is a problem of dysfunction and is not characterized by prominent
neuronal loss (Morrison & Hof, 1997; Yankner, Lu, & Loerch, 2008). Stereological cell counting
methods indicate almost no age-related neuronal loss in the hippocampi of rodents (Rapp &
Gallagher, 1996), non-human primates (M.J. West, Amaral, & Rapp, 1993), and humans (M. J.
West, 1993). Further, there are no documented age-related changes in the basic cellular
characteristics (resting membrane potential, amplitude and duration of action potentials) of
hippocampal neurons (Rosenzweig & Barnes, 2003). Given that the changes in hippocampal
cellular structure and properties are not prominent in aging, it is important to turn our attention
and research focus to the functional molecular mechanisms at the synapse that might deteriorate
with age. Indeed, fine synaptic changes and alterations in the neurochemical environment of the
synapse can precede the cognitive and gross structural changes that occur as a part of aging and
AD, by several years (Walsh & Selkoe, 2004). Since the functional changes underpinning the
putative relationship between hippocampal structural integrity and memory remain unclear,
investigating age-related differences in neurochemical foundations of memory processes may
shed light on the neural mechanism of memory declines in aging.
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1.2.2 Glutamatergic neurotransmission in memory function
Investigation of the neural mechanisms of memory function has a long history in
experimental and theoretical neuroscience, which links memory formation to cellular structural
plasticity (Chen & Tonegawa, 1997; Hebb, 1949) driven by long-term potentiation (LTP, (Bliss
& Collingridge, 1993; Kauer, Malenka, & Nicoll, 1988; Lynch, 2004; Nicoll, 2017)). LTP is the
cellular mechanism of information storage that modifies the synaptic connections, increases their
strength over time, in turn strengthening the encoded memory (Rolls et al., 2002). The necessary
condition for LTP and, by implication, memory formation, is the activation of glutamatergic
ionotropic N-methyl-D-aspartate (NMDA) receptors that are richly represented in the
hippocampus (McEntee & Crook, 1993). Glutamate is the major excitatory neurotransmitter in
the mammalian brain, with 80% of cortical neurons being glutamatergic. Glutamatergic NMDA
receptors play a role in long term memory formation via synaptic plasticity mediated by LTP
(Hebb, 1949). LTP depends on correlated and coincident pre- and post-synaptic activity
efficiently supported by NMDA receptors by virtue of being molecular coincidence detectors
(Tabone & Ramaswami, 2012). Specifically, pre-synaptic depolarization releases glutamate that
rapidly diffuses through the synaptic cleft and binds the post-synaptic NMDA receptor, bringing
about depolarization of the post-synaptic membrane. This depolarization relieves the NMDA
receptor of the voltage dependent magnesium (Mg2+) block, thus, allowing the influx of calcium
(Ca2+) ions that carry out the downstream events to trigger LTP (Rosenzweig & Barnes, 2003;
Tatti, Haley, Swanson, Tselha, & Maffei, 2017). By detecting coincident pre- and post-synaptic
depolarization, the NMDA receptors ensure that LTP is restricted to the synapses that display
this activity. Increase in excitatory neurotransmission is also accompanied by increased synthesis
of glutamate.
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Overexpression of NMDA receptors in rodent hippocampi and the ensuing augmentation
of synaptic potentiation therein, result in improved spatial learning and memory as assessed
using the Morris water maze (Tang et al., 1999). Conversely, selective ablation of NMDA
receptors in the hippocampi of adult mice profoundly impairs the recall of associations learned
during the water maze task (Magnusson, Brim, & Das, 2010; Morris, Anderson, Lynch, &
Baudry, 1986). Pharmacological agents that support the activation of glutamate receptors show a
reversal of the cognitive deficit (Müller, Scheuer, & Stoll, 1994). This suggests a dependence of
associative recall on NMDA receptor sensitivity and glutamatergic neurotransmission in the
hippocampus. A direct relationship between the firing rates of hippocampal glutamatergic
neurons and acquisition of new associative memories (Suzuki, 2007) also supports hippocampal
glutamatergic involvement in learning and memory.
Delayed induction and inefficient maintenance of LTP occur with aging (G. Diana, Scotti
de Carolis, Frank, Domenici, & Sagratella, 1994) and may be supported by well-documented
age-associated declines in the number, binding efficiency, and electrophysiological functions of
hippocampal NMDA receptors (Magnusson et al., 2010; Müller, Stoll, Scheuer, & Meichelbock,
1994; Rosenzweig & Barnes, 2003). It is in fact suggested that cognitive deficits induced
experimentally using NMDA receptor antagonists mimic, in many ways, those seen as a part of
age-related cognitive impairments (Müller, Stoll, et al., 1994). Therefore, investigating
hippocampal synaptic activity such as glutamate modulation during memory performance may
offer a key to understanding age-related memory decline.
1.2.3 Physiological basis of glutamatergic neurotransmission: The Glutamate-Glutamine cycle
It is important to understand the physiological bases of neurotransmission in order to
appreciate the glutamatergic dynamics that occur during neuronal engagement. Neuronal
response to stimulation prompts changes in neurovascular and neurometabolic processes such as
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increase in cerebral blood flow, glycolysis and oxidative metabolism, synthesis of
neurotransmitters such as glutamate, as well as increase in neurotransmission (Mergenthaler,
Lindauer, Dienel, & Meisel, 2013; Rothman, Behar, Hyder, & Shulman, 2003).
Glucose is the primary source of energy for sustaining the above-mentioned processes
under non-fasting conditions. After being taken up by astrocytes (via glucose transporter,
GLUT1) and neurons (via GLUT3), glucose undergoes glycolysis to generate pyruvate that then
enters the mitochondrial tricarboxylic acid (TCA) cycle of oxidative metabolism. Astrocytes and
neurons have their own TCA cycles. Astrocytes, owing to the presence of pyruvate carboxylase,
are the only cells that can synthesize new glutamate via α-ketoglutarate (a TCA cycle
intermediate), and transfer it to neurons in the form of glutamine. As explained below, presynaptic neurons convert glutamine to glutamate and package it into vesicles with the help of
vesicular glutamate transporters (vGLUTs). Vesicular glutamate is released into the synaptic
cleft upon depolarization induced by increased neuronal activity. Following its release from the
pre-synaptic terminal, glutamate binds post-synaptic NMDA receptors to start the processes of
LTP generation. Excess synaptic glutamate is taken up by astrocytes to ensure that extracellular
levels of glutamate are kept low in order to prevent excitotoxicity. Inside astrocytes, glutamate is
converted predominantly to glutamine by glutamine synthetase, an enzyme found only in these
cells. Glutamine released by the astrocytes is taken up by the pre-synaptic neuron and converted
to glutamate by glutaminase, thus completing the glutamate-glutamine cycle (Rothman et al.,
2003; Shen et al., 1999). Glutamate not only acts a neurotransmitter and a metabolic substrate for
the TCA cycle, but also as a precursor for glutamine and GABA (the main inhibitory
neurotransmitter). The glutamate-glutamine neurotransmitter cycle serves to replenish glutamate
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after its release and is thus, crucial for proper regulation of glutamatergic neurotransmission. A
simplified schematic of the glutamate-glutamine cycle is depicted in Figure 1.

Figure 1. Glutamate-Glutamine cycle. A simplified cartoon of the glutamate-glutamine cycle
depicting the main players involved. Glutamate released into the synaptic cleft from the
presynaptic neuron binds postsynaptic NMDA receptors (NMDAR) to start the cascade leading
to LTP. Extra glutamate in the synaptic cleft is taken up by astrocytes and converted to
glutamine, which is released and taken up by the presynaptic neuron. Inside the neuron,
glutamine is converted back to glutamate, thus, completing one round of the glutamate-glutamine
cycle.

The human brain, comprising only 2% of the total body weight, utilizes 20% of the
body’s glucose (energy), thus, having the highest energy demand than any other organ in the
body (Sokoloff et al., 1977). Majority of the brain’s energy is provided by the TCA cycle
(oxidative metabolism), with glycolysis playing a transient role. Glycolysis is inefficient since it
produces less energy (only 2 ATPs); whereas the TCA cycle produces about 34 ATPs, making it
energetically more efficient. The TCA cycle can also operate on its own since amino acids
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entering it can continue to cycle and generate energy. Since glutamate is the most abundant
excitatory neurotransmitter in the brain, most of the brain’s energy is spent on glutamatergic
neurotransmission, with almost 80% of the energy obtained from glucose oxidation being used to
power the glutamate-glutamine cycle. Even in an awake, resting state, there is ongoing energy
(glucose) consumption by the brain, about 20-40% of which is for internal housekeeping
processes such as maintenance of resting membrane potentials, and 60-80% for cortical signaling
and neuronal activity (Rothman et al., 2003). The glutamate-glutamine cycle is, thus, the major
metabolic energy consuming pathway in the human cortex (Shen et al., 1999), with increase in
neural activity and energy demand resulting in increased synthesis of glutamate and
glutamatergic neurotransmission. Prior investigations have measured the rates of the glutamateglutamine and the metabolic TCA cycles by tracking the flux of radiolabeled carbon isotope
(13C), following infusions of exogenous substrates such as D-glucose, across the intermediates of
these cycles (Shen et al., 1999; Sibson et al., 1998). Cell culture studies, as well as 13C magnetic
resonance spectroscopy (13C MRS) in rodents and humans, have revealed a tight coupling
between the rates of the glutamate-glutamine cycle (i.e. excitatory neurotransmission) and the
TCA cycle (oxidative metabolism of glucose) (Hyder et al., 2006; Sibson et al., 1998) (see
review (Rothman, De Feyter, De Graaf, Mason, & Behar, 2011)). There is, in fact, a 1:1
stoichiometry where one molecule of glutamate released and cycled requires the oxidation of one
molecule of glucose, linking the elevated neuronal spiking activity and excitatory
neurotransmission to increased metabolic activity, in order to support cellular energy demands.
The neurotransmission and metabolic energy-generating processes in response to neuronal
activation and excitatory glutamatergic neurotransmission are thus, tightly coupled. Increases in
glutamate levels during neuronal stimulation can be interpreted as a biomarker of task-induced
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increases in glutamate, metabolic demand, excitatory neurotransmission, and the ensuing
changes in synaptic plasticity.
1.2.4 Excitatory/inhibitory (E/I) balance in the brain
Up to 80% of cortical and hippocampal neurons are excitatory with glutamate as their
principle neurotransmitter, and the remaining 20% are inhibitory with γ-aminobutyric acid
(GABA) as their main neurotransmitter. Importantly, glutamatergic and GABAergic neurons are
closely integrated into neural ensembles within local and long-range circuits, work in concert to
process input signals, and drive the brain’s excitatory/inhibitory (E/I) balance (Tatti et al., 2017).
Neural activity shifts the E/I balance towards a wide spectrum of excitation and inhibition
required to meet task demands, eventually taking the brain to new metabolic steady-state levels.
The fluctuations in the E/I balance during neuronal stimulation eventually give rise to synaptic
remodeling resulting in synaptic plasticity. Synaptic strength and cellular excitability are
continually adjusted to maintain the E/I equilibrium and homeostasis, to ensure stable
neurotransmission and optimal synaptic performance. Even though the focus of this dissertation
is glutamate, it is important to remember that GABA, the dominant inhibitory neurotransmitter,
is the complementary player crucial for maintaining the E/I balance. Age-associated changes can
be detected at excitatory as well as inhibitory synapses and can lead to disruption of the E/I
balance, thus causing instability of the neuronal ensemble to possibly result in age-related
cognitive impairment. Owing to the importance of the glutamate and GABA neurotransmitter
systems in shifting the E/I balance and evaluating the brain’s response to stimulation, it is crucial
to employ non-invasive methods to measure the dynamics of these neurotransmitters in vivo in
humans.
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1.2.5 Non-invasive measurement of in vivo glutamate levels
Until some years ago, studies of glutamate’s role in memory had been restricted to
animals, mainly rodent models, and employed invasive techniques such as micro dialysis or
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MRS to measure levels of metabolites. In vivo proton magnetic resonance spectroscopy (1H
MRS) that enables the non-invasive quantification of regional brain levels of neurometabolites,
including glutamate, has helped translating this research into the human realm (J. A. Stanley,
2002; J. A. Stanley, Pettegrew, & Keshavan, 2000). 1H MRS is an analytical and quantitative
technique, an advancement to which, in the form of functional 1H MRS (1H fMRS) has been
made possible due to improved hardware and magnets with higher field strengths and better
signal acquisition schemes (J. A. Stanley & Raz, 2018). 1H fMRS is the only non-invasive
technique that can measure, in vivo, the temporal dynamics of glutamate modulation in response
to stimulation. The high temporal resolution afforded by 1H fMRS allows tracking of changes in
glutamate levels at a sub-minute time scale. Studies have shown increases in levels of glutamate
in the visual (Bednařík et al., 2015; Mangia et al., 2007; Schaller, Mekle, Xin, Kunz, & Gruetter,
2013) and motor (Schaller, Xin, O'Brien, Magill, & Gruetter, 2014) cortices upon stimulation of
those areas using appropriate paradigms. Increased modulation of glutamate in the dorsolateral
prefrontal cortex has been demonstrated during a working memory task (Woodcock, Anand,
Khatib, Diwadkar, & Stanley, 2018). The first study to demonstrate task-related modulation of
glutamate in the hippocampus was by Stanley et al (J.A. Stanley et al., 2017), where unique
temporal dynamics of glutamate were shown to exist during the encoding and retrieval stages of
an associative memory task. In that study, characterized by a 54 s temporal resolution, the stages
of memory encoding and retrieval were clearly differentiated by the temporal pattern of
glutamate modulation. Importantly, that study showed that, early modulation of glutamate,
specifically during encoding, predicted faster learning of associations, explained by the early
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functional engagement of the hippocampus during encoding. After the initial rise, glutamate
levels were shown to decrease and level off, indicating successful consolidation, without the
need to elevate glutamate further. Stanley et al, thus, established the ability and sensitivity of 1H
fMRS to measure task-related temporal dynamics of hippocampal glutamate during cognitive
performance. The Stanley et al (2017) study was conducted in healthy young adults and formed
the basis and motivation of the current dissertation study extended to healthy old adults. It is
unknown whether similar unique glutamate dynamics exist during memory encoding and
retrieval in the elderly, and whether there are age differences in glutamate modulation during
associative memory performance.
Glutamate levels and changes therein that are detected by 1H fMRS in the selected voxel
reflect the net cortical output driven by the E/I balance. An increase in synaptic excitability is
reflected as a relative increase in glutamate, which is measured by 1H fMRS. Lower excitability,
reflected by lower measured glutamate levels, indicates a decrease in excitability balanced by
increase in the inhibitory drive due to a shift in the E/I balance. It is thus, important to remember
that the glutamate signal measured by 1H fMRS is not a binary brain response to stimulation but
reflects a new steady-state achieved by the brain, by shifting the E/I balance, to meet task
demands. The use of 1H fMRS also points to the importance of evaluating the dynamics of taskrelated changes in glutamate (and GABA) for elucidating behaviorally pertinent neural output
driven by shifts in the E/I balance. The importance of 1H fMRS is emphasized by reiterating that
the association between increased glutamate-glutamine cycling (excitatory neurotransmission)
and increased glutamate synthesis (via glucose oxidation) is a fundamental cellular framework
that provides the interpretation of glutamate modulation measured by 1H fMRS. Further
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information on the principles and methodology of 1H MRS, along with its applications and
limitations, are included in Chapter 2.
1.3 Project scope and aims
The selective vulnerability of associative memory to aging has been tested using various
paradigms, and the results support the ADH (Naveh-Benjamin, 2000). Possible age effects on the
machinery required for LTP induction and maintenance as well as on energy metabolism point to
the prospect of age differences in glutamate dynamics contributing to those in memory
performance. This might present itself as an inability of older adults to modulate hippocampal
glutamate levels in response to memory function. The fact that glutamatergic NMDA receptors
richly represented in the hippocampus mediate synaptic plasticity, with increases in hippocampal
neuronal spiking coinciding with memory consolidation, and the tight relationship between the
metabolic and neurotransmitter pools of glutamate, all together support a direct link between
memory consolidation, increased hippocampal neuronal activity, glucose metabolism, glutamate
synthesis, and glutamate-glutamine cycling/neurotransmission. This forms the premise of
characterizing glutamate dynamics as measured by ¹H fMRS under task-active conditions.
Relevant to this study is that, levels and temporal dynamics of glutamate during associative
memory performance can be measured in vivo using ¹H fMRS (J.A. Stanley et al., 2017).
Moreover, the sub-minute temporal resolution of glutamate measurements allows the
characterization of glutamate modulation during the individual stages of memory function
(encoding and retrieval) using ¹H fMRS.
The main goal of this dissertation was to test the existence of age differences in
hippocampal glutamate modulation in response to associative memory function, and their
relationship to performance using an object-location associative memory task. This study was
developed based on the previous study that demonstrated unique temporal dynamics of glutamate
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during memory encoding and retrieval, with early glutamate modulation during encoding
predicting faster learning (J.A. Stanley et al., 2017). In the current study, I hypothesized that age
differences in hippocampal glutamate modulation do exist and are specific to associative
encoding. The previous study (J.A. Stanley et al., 2017) also led me to hypothesize that not only
age differences in, but also the timing of, glutamate modulation during encoding is related to
associative memory performance. The proposed framework of this investigation is schematically
represented in Figure 2. There were three main aims of this dissertation.
1. To evaluate age differences in performance on an object-location associative learning
and memory task.
2. (a) To examine age differences in hippocampal glutamate levels during a non-taskactive control condition.
(b) To examine age differences in hippocampal glutamate modulation during
associative learning and memory function.
3. To investigate if the timing of glutamate modulation underlies age differences in
memory function.
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Figure 2. The proposed framework. Associative memory function
involving the hippocampus and glutamate results in glutamate
modulation that in turn supports task performance.

Glutamate levels during encoding and retrieval in two extreme age groups of healthy
young and old adults were recorded while they performed an object-location associative memory
task. The first aim of this study sought to confirm age differences in the associative memory task
that was further applied to investigate task-induced glutamate modulation. To achieve this aim, it
was necessary to first validate and pilot the existing object-location associative memory task
(used in the previous study (J.A. Stanley et al., 2017) mentioned above), to test for ceiling effects
if any, and appropriately modify the task to allow both age groups to reach their optimum levels
of learning. Various learning curve fitting functions were evaluated to appropriately characterize
the learning behavior.
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The second aim included testing for the relationship between associative memory
performance and glutamate levels obtained during a non-task-active control condition i.e.
‘control-level glutamate’. The control conditions employed in this study were the flashing
checkerboard and fixation cross (see Chapter 3 Methods) that provided steady-state levels of
hippocampal glutamate to be compared to glutamate levels acquired during the associative
memory task. The second aim also tested for age differences in the temporal dynamics
(modulation) of glutamate during associative memory performance, as opposed to examining
steady-state levels thereof during the control condition. It was hypothesized that age differences
in glutamate modulation do exist and show specificity towards memory encoding. The use of
proton functional magnetic resonance spectroscopy (1H fMRS) to measure glutamate modulation
in different brain regions has been validated using several sensory and cognitive paradigms (see
Chapter 2). 1H fMRS is the only non-invasive method for exploring hippocampal glutamate
modulation in response to associative memory function.
Finally, this study aimed to investigate a potential functional biomarker of cognitive
performance and decline. The third aim of this dissertation, thus, tested whether age differences
in glutamate modulation during memory encoding were related to those in memory performance.
Based on the previous study (J.A. Stanley et al., 2017) that demonstrated early glutamate
modulation being predictive of faster learning in young adults, I hypothesized here, that the
timing of glutamate modulation is related to associative memory performance in old adults as
well, with early modulation indicating early engagement of the hippocampus, and better
performance. In addition, I hypothesized that control-level glutamate is related to associative
memory performance. Elucidating such relationships between neurochemicals (specifically an
excitatory neurotransmitter such as glutamate) and cognition is critical because it can provide a
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better understanding of the possible effects of age on neurotransmission and neurometabolism,
which in turn affect cognition in normal as well as pathological aging manifested as AD and
other dementia.
This dissertation is structured as follows. The basics of 1H MRS, along with its
applications and limitations, are introduced in Chapter 2. Chapter 3 describes the cognitive,
neuroimaging, and statistical methods applied in this study to explore the specific aims
mentioned above. Chapter 4 describes the results and finally, Chapter 5 summarizes and
discusses the findings of this study while also describing limitations and future directions.
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INTRODUCTION TO MAGNETIC RESONANCE SPECTROSCOPY
Magnetic Resonance Spectroscopy (MRS) is based on the phenomenon of nuclear
magnetic resonance (NMR) and is one of the oldest analytical techniques used to non-invasively
measure levels of metabolites in samples such as body tissues. While an extensive review of
MRS is beyond the scope of this dissertation manuscript, a summary of relevant concepts is
nevertheless provided and more details on the subject can be found elsewhere (De Graaf, 2007;
van der Graaf, 2010).
2.1 Evolution of the MRS signal
In NMR, atomic nuclei possessing an internal magnetic moment and a non-zero spin
align with the external magnetic field (B0) to gain angular momentum and precess at their
characteristic resonant frequency called Larmor frequency (ω). The Larmor frequency (equation
1) is equal to B0 times the gyromagnetic ratio – an intrinsic property of the nucleus being studied.
The gyromagnetic ratio is the ratio of the magnetic moment to the angular momentum of the
nucleus (i.e. spin-1/2 for proton), and for a proton it is approximately 42.58 MHz T-1 (megahertz
per Tesla).
The Larmor frequency is given by the following equation:
𝜔 = 𝛾𝐵0

(1)

where, γ = gyromagnetic ratio and Bo = external magnetic field.
The evolution of the MRS signal can be explained in brief as follows. Initially, when all
nuclei are aligned with the B0 magnetic field, the net longitudinal magnetization is maximum.
Upon exposure to an applied magnetic field (B1) generated by radiofrequency (RF) pulses and
perpendicular to B0, the nuclei change their orientation away from B0 and to the transverse plane.
T1 relaxation is the process by which net magnetization that has been tipped by the RF pulse,
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returns to equilibrium (longitudinal relaxation). On the other hand, T2 relaxation is when the
transverse magnetization decays after the RF pulse. However, inhomogeneities in the magnetic
field result in shortening the T2, and this effective decay time is called T2*. During relaxation
back to equilibrium, the nuclei produce a decaying RF signal called the free induction decay
(FID) that is detected by the receiver coil. This is the time-domain signal since it is dependent on
the time taken by the signal to decay (T2*). Applying a Fourier transform to the time-domain
signal provides the frequency components making up the signal and are in the form of peaks
along a frequency axis (called the chemical shift axis, see section 2.1.1). This is referred to as a
spectrum. At a given frequency, the area under each peak is proportional to the number of nuclei
that contribute to the signal at that frequency, and thus, proportional to the concentration of the
metabolite that contains those nuclei of interest. It is important that the spectrum be made of
sharper, taller, and well-separated peaks, leading to better resolution. The shape of the peak is
strongly affected by the decay rate of the FID, where a slower decay results in taller and
narrower peaks and a faster decay results in shorter and broader peaks. The area under the peak
and the measured concentration of the metabolite always remain the same irrespective of the
shape of the peak.
Although MRS can detect any nucleus with a magnetic moment, such as proton,
phosphorus, carbon (1H,
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P,

13

C); the most commonly studied nucleus for biological

applications is the proton (hydrogen nucleus, 1H) owing to its high sensitivity and high natural
abundance in the body. The majority of metabolites involved in cellular function including
components of the cell membrane as well as neurotransmitters contain protons, making it
possible to investigate them simultaneously using proton MRS (1H MRS). 1H MRS can reliably
detect metabolites with concentrations equal to or greater than 0.5 to 1 mmol/kg wet weight
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(w.w.). (Govindaraju, Young, & Maudsley, 2000). Accurate identification and quantification of
the proton-containing metabolites depend on a priori knowledge, as well as efficient separation
and resolution of the peaks that in turn depend on several factors that are described in brief
below.
2.1.1 Chemical shift
1

H MRS provides a chemical profile, or an in vivo non-invasive “biochemical biopsy”, of

a selected region of interest (ROI) in an organ, owing to its capacity to resolve and quantify
specific proton-containing chemical species. Brain metabolites such as N-acetyl-aspartate
(NAA), glycerophosphocholine + choline (GPC+PC), Phosphocreatine + creatine (PCr+Cr),
glutamate (Glu), and myoinositol (mI) can be conveniently measured using 1H MRS. Each
metabolite is characterized by spin groups such as -CH, -CH2, -CH3, NH3 depending on its
chemical structure. The unique chemical structure of each metabolite and the electron cloud
around the nucleus of interest (here, proton) produces a shielding effect that modifies, and
decreases the strength of, the local magnetic field experienced by the nucleus (Figure 3). For
instance, water has a simple chemical structure (H2O) and thus, experiences the least shielding
effect; whereas lipids with more complex structures experience more shielding. Shielding causes
identical nuclei to experience different local magnetic fields, resonate at different frequencies,
resulting in their separation from one another along the frequency axis - called the ‘chemical
shift’ axis.
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Figure 3. Effect of shielding on chemical shift. A schematic explaining the shielding of a proton
by its electron cloud resulting in the modification of the local magnetic field experienced by the
proton.

Metabolites are thus, identified by their unique chemical shifts along the frequency axis
of the spectrum. For instance, although glutamate and myoinositol, both are proton-containing
metabolites, their unique chemical structure and environment will make them occupy different
positions on the chemical shift axis owing to the different local magnetic fields that they
experience. Chemical shift scales with magnetic field strength, with higher strengths affording
more separation (in Hz) and resolution of the metabolites. The frequencies along the chemical
shift axis are presented as parts per million (ppm). Table 1 lists the major metabolites identifiable
using 1H MRS, along with their chemical shifts.
2.1.2 Scalar (J) coupling
Spectral peaks are either prominent singlets as in NAA, choline, creatine, or can also be
split to give doublets, triplets or multiplets. This splitting of spectral peaks occurs due to the
‘through-bond’ interaction between adjacent spin groups on the same molecule. This
phenomenon is called J coupling. It provides information about the distance and angle of
chemical bonds between two spin groups within the metabolite. The J coupling constant
determines the spacing between the subpeaks in a multiplet. Unlike chemical shift, J coupling is
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not dependent on the strength of the external magnetic field. Table 1 lists the major metabolites
identifiable using 1H MRS, along with their spin groups, multiplicity, and chemical shifts.
Table 1. List of common proton-containing metabolites. The following are common
proton-containing metablites observed in vivo, with their spin groups, multiplicity, and
chemical shift positions (Govindaraju et al., 2000).
Metabolite
myoinositol (mI)
GPC + PC

PCr + Cr

GABA

Glutamine

Glutamate

NAA

Lactate

Spin group

Multiplicity

CH
CH
N(CH3)3
CH2
CH2
N2(CH3)
CH2
NH
CH2
CH2
CH2
CH
CH2
CH2
NH2
CH
CH2
CH2
CH3
CH
CH2
NH
CH
CH3

doublet
triplet
singlet
multiplet
multiplet
singlet
singlet
singlet
multiplet
quintet
triplet
triplet
multiplet
multiplet
singlet
doublet
multiplet
multiplet
singlet
doublet
doublet
doublet
quartet
doublet

Chemical shift (ppm)
3.52
3.61
3.18
4.05
3.5
3.03
3.91
6.65
3.01
1.89
2.28
3.75
2.13
2.45
6.82
3.74
2.03
2.35
2.01
4.38
2.67
7.82
4.09
1.31

Note: Glycerophosphocholine + choline: GPC+PC, Phosphocreatine + creatine: PCrCr, N-acetyl
aspartate: NAA. Only a few main representative spin groups per metabolite are mentioned. For
an extensive list refer to (Govindaraju et al., 2000).
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2.1.3 Signal acquisition scheme
Single voxel spectroscopy (SVS) uses three slice selective RF pulses in the presence of
three orthogonal B0 gradients to select a voxel at the intersection of the three slices. These
orthogonal RF pulses generate a spin echo of the spins inside the voxel. One should make sure
that the voxel is placed appropriately in the region while minimizing contamination from the
adjacent tissue. Voxel placement can become tricky when acquiring signal from more internal
and convoluted brain regions such as the hippocampus. One of the two SVS sequences
commonly used (and applied in this study) is Point Resolved Spectroscopy (PRESS). PRESS
utilizes three RF pulses: a 90º pulse followed by two 180º pulses, with each pulse having a sliceselective gradient along one of the three principle axes (X, Y, Z). This ensures that only the
protons in the cuboid created at the intersection of the gradients experience the three RF pulses.
2.1.4 Assuring the MRS signal quality
2.1.4.1 Water suppression
Since water is the largest contributor to the number of protons in the body, signals arising
from it must be efficiently suppressed to allow the detection of metabolites that are at much
lower concentrations. Water suppression is done using methods such as variable power and
optimized relaxation delays (VAPOR) (Tkáć & Gruetter, 2005) that utilize a very narrow
bandwidth selective for the frequency of water. In addition, outer volume suppression (OVS) is
performed to improve the definition of the ROI by eliminating the signals coming from outside
the voxel as well as from lipids (Tkáć & Gruetter, 2005). In the current study, VAPOR and OVS
were implemented as a part of the acquisition sequence (PRESS).
2.1.4.2 Shimming
Improved resolution of the metabolite spectra depends not only on the magnetic field
strength, but also on the homogeneity of the magnetic field in the voxel. Even though higher
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magnetic field strength affords better spectral resolution and chemical shift dispersion, it is
accompanied by the issue of possible magnetic field inhomogeneity due to factors such as voxel
placement near air-filled cavities (sinuses) and increase in iron deposition due to old age, for
instance. Poor magnetic field homogeneity results in variable magnetic field strength in the ROI,
thus, creating large variances in precession frequencies. This results in broader and overlapping
peaks in the frequency domain and weakens the ability of MRS to resolve the spectra. In
shimming gradients through shim coils are iteratively adjusted to optimize the homogeneity of
the magnetic field over the voxel of interest. It is mostly automated but may be complemented
with manual adjustments. Automated shimming is done using algorithms such as Fast Automatic
Shim Technique using Echo-planar Signal readout for Mapping Along Projections
(FASTESTMAP) (Gruetter & Tkác, 2000). Manual adjustment of gradients through the shim
coils might be required especially in challenging situations such as imaging an ROI in an aging
brain. Brains of the elderly have higher iron accumulation in regions such as the hippocampus
(Haacke et al., 2005) resulting in higher B0 inhomogeneity. Manual shimming, although timeconsuming, is necessary for acquisition of cleaner spectra. Poor shimming can result in broad
spectral peaks leading to lower accuracy in quantifying metabolites.
2.1.4.3 Signal averaging
SVS, as its name suggests, can acquire signal only from a single localized ROI at a time.
It requires averaging of multiple scans to improve the signal to noise ratio (SNR), resulting in a
spectrum of good quality. Noise scales inversely with the square-root of the number of signal
averages and signal scales directly with the number of signal averages. Although averaging
prolongs acquisition, its effect on reducing noise makes it a critical aspect of MRS.
Additional factors critically affect the quality of the MRS signal. A larger voxel size is
preferred owing to low concentrations of the metabolites of interest; however, at the expense of
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partial volume. Higher magnetic field strength reduces the degree of spectral overlap by
increasing the chemical shift dispersion, leading to better and more accurate spectral resolution
and better SNR. In fact, at very high field strengths (7T and higher) greater spatial resolution can
be achieved by employing smaller voxels while minimizing the problem of partial volume of
different tissue types (gray matter, white matter, CSF) within the localized voxel. The echo-times
(TE) used in MRS studies may be long (> 135 ms) to acquire only the prominent singlets (NAA,
GPC+PC, PCr+Cr) or short (< 35 ms) to acquire singlets as well as multiplets (glutamate,
glutamine, myoinositol). TE depends on the decay time constant, T2, which is different for
different metabolites. Longer TE will not be able to capture the signal from metabolites with
shorter T2 values since the signal will have already decayed. On the other hand, at short TE, all
metabolites will have maximum signal since less time will be available for them to undergo T2
decay. The shortest TE thus results in the smallest T2 losses. The repetition time (TR) should be
optimized to allow enough time between excitations to ensure sufficient relaxation of the signal
before the next excitation. TR depends on the relaxation time constant, T1, which is different for
different metabolites. Ideally, the TR must be at least three (preferably five) times the longest T1
to allow full recovery of the signal. If TR is not optimum, the observed signal will have an
amplitude that is lower than a fully relaxed signal (J. A. Stanley et al., 2000). This is called
partial saturation. TRs between 2-5 seconds are considered optimal.
2.2 MRS data processing and fitting
2.2.1 Eddy-current, phase, and shift corrections
Eddy currents are electrical currents induced by a rapidly changing magnetic field due to
a conducting material moving in the magnetic field and can cause time-varying shifts in the main
magnetic field. Eddy currents generate a decaying signal with varying amplitude and phase.
Thus, the acquired signal is no longer a pure MR signal, but a distorted FID, which upon Fourier
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transformation can result in imperfect spectra. During data acquisition the signal from water is
suppressed. However, a separate water-unsuppressed spectrum is acquired from the same voxel
after data acquisition, using the same data acquisition parameters. Phase information from the
water-unsuppressed spectrum is used to correct the water-suppressed spectra (Klose, 1990) by
cancelling the influence of the Eddy currents. Acquisition of this extra water-unsuppressed
spectrum requires about 2-4 averages and adds about half a minute to the overall procedure but
helps improve spectral quality.
The signal is made of real (absorption) and imaginary (dispersion) components that are
90º out of phase with each other. After Fourier transform, phase correction is applied to the
spectrum to bring all peaks into the absorption mode. Phasing thus, applies an adjustment to the
spectrum to display the optimal spectral form and is mostly automated on many MRI scanners.
Phasing can be zero-order (frequency independent) and first-order (frequency dependent). Zeroorder phase correction is applied equally to all peaks in the spectrum and is done by adjusting the
phase correction factor until all peaks are aligned in the same direction. Frequency-dependent
phase errors occur during the delay between excitation and signal reception, where after being
tipped into the transverse plane, the nuclei start dephasing based on their frequencies. Such errors
are corrected using first-order phasing where the phase correction factor changes according to
the different frequencies. In addition, frequency errors that might be caused due to temporal
drifts in B0 can be corrected by moving a reference peak of the spectrum to its theoretical
position, or entering a numeric value at the scanner control panel
2.2.2 Spectral fitting
Spectral fitting can be performed either in the time-domain or in the frequency-domain.
For the current study, spectral fitting was done in the frequency-domain. Precise and accurate
quantification of metabolites requires that the metabolite peaks not only be well-resolved but
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also have a narrow linewidth (full-width half-maximum, FWHM). Any user-bias that may
accompany spectral enhancements is avoided by employing a fully automated processing and
fitting approach. The most common curve-fitting approach for MRS is LCModel (Provencher,
1993). Acquired in vivo spectra are analyzed as a linear combination (LC) of the spectra from the
LCModel simulated basis set of 20 metabolites. LCModel fitting incorporates a priori
knowledge of the chemical shifts, J-coupling constants, lineshape function, number of peaks,
phase, and amplitude of the basis set and ensures improved specificity of resolving overlapped
resonances (peaks).
The uncertainty in spectral fitting, i.e. the difference between acquired and modeled
spectra, is expressed as a Cramér-Rao lower bound (CRLB) value (Cavassila, Deval, Huegen,
van Ormondt, & Graveron-Demilly, 2001). CRLB is the threshold of the error associated with
model fitting and reveals uncertainties in the fit. CRLB can be expressed either as a percentage
(relative CRLB) or as an absolute value (Kreis, 2016). Relative % CRLB values have been
routinely used as a quality filter for spectra; however, the thresholds are arbitrarily determined,
leading to a possible bias. Spectra with CRLB values higher than a certain threshold indicate less
reliable measures and are commonly excluded from further analyses. The CRLB threshold can
depend on the study as well as on the ROI from which spectra are acquired. It is optimum to use
absolute CRLB values, measured in comparison to a control group or to normal metabolite
levels, as quality control criteria. The absolute CRLB value is determined based on a cutoff set at
the mean CRLB plus two standard deviations obtained from a control population (Kreis, 2016).
This means spectra with CRLB values more than this cutoff will be excluded from analyses.
LCModel fitting of data may or may not be followed by further spectral averaging to
achieve improvements in the SNR. Averaging is mainly done for experiments with block designs
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where consecutive blocks of the stimulation can be averaged to further improve the SNR. This
will be explained in detail in the ‘image post-processing and quantification of the spectra’ section
of Chapter 3.
2.3 Absolute quantification of metabolite levels
Absolute concentrations of metabolites in mmol/kg.w.w. are calculated as:
[𝑚𝑒𝑡𝑎𝑏𝑜𝑙𝑖𝑡𝑒] = [𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒] ∗

𝑆(𝑚𝑒𝑡𝑎𝑏𝑜𝑙𝑖𝑡𝑒)
𝑆(𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒)

∗ (1 − 𝑓𝐶𝑆𝐹 )

(2)

where, [metabolite] and [reference] are the concentrations (number of protons) in the metabolite
and reference, respectively, S is the signal amplitude, and fCSF is the fraction of CSF in the
sample tissue volume. The 1 - fCSF adjustment factor is for partial volume correction, and also
corrects for the fact that the metabolites are almost all concentrated in the gray and white matter.
The reference is a compound of known concentration against which the areas occupied
by metabolite peaks are compared and metabolite concentrations are quantified. The
unsuppressed water signal collected from the same voxel during data acquisition is the reference
used for the absolute quantification of metabolites. The concentration of water is calculated
based on the tissue segmentation (gray and white matter) information that is obtained from
structural T1-weighted (e.g. MPRAGE) image processing. The concentration of pure water is
55.6 moles/l. The total tissue water is assumed to be (J. A. Stanley, Drost, Williamson, &
Thompson, 1995):
[𝐻2 𝑂] = ((0.81 ∗ 𝑓𝐺𝑀 ) + (0.71 ∗ 𝑓𝑊𝑀 )) ∗ 55.6 ∗ 103 mM

(3)

where, fGM and fWM are fractions of gray and white matter in the sample tissue volume,
respectively. The concentration of pure water is 55.6, and 0.81 and 0.71 are the fractions of MRvisible water in gray and white matter, respectively (Ernst, Kreis, & Ross, 1993; J. A. Stanley et
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al., 1995). Corrections for signal attenuation due to T1 and T2 relaxation effects are also applied
as:
𝑆(𝑚𝑒𝑡𝑎𝑏𝑜𝑙𝑖𝑡𝑒𝑟𝑒𝑙𝑎𝑥𝑒𝑑 ) =

𝑆(𝑚𝑒𝑡𝑎𝑏𝑜𝑙𝑖𝑡𝑒)
exp(−

𝑇𝐸
TR
)∗(1−exp(− ))
𝑇2
T1

(4)

where, S(metaboliterelaxed) is the fully relaxed signal of the metabolite and S(metabolite) is the
observed signal of the metabolite (Gasparovic, 2006)
Metabolite concentrations can also be expressed as a ratio to an internal reference
metabolite, which most of the times is total creatine. However, it is misleading to assume that
total creatine levels always remain constant (Kreis, Ernst, & Ross, 1993), since they can change
during various stages of development as well as during pathology.
2.4 Applications of 1H MRS
So far, the most popular method to examine the neural correlates of the brain’s response
to stimulation has been fMRI that is based on the Blood Oxygen Level Dependent (BOLD)
signal. Although characterized by better spatial and temporal resolution, the BOLD signal is a
proxy for neuronal response. It increases upon neuronal activation and cannot differentiate
between the contribution of excitatory and inhibitory activity. Neuronal activity induced by
stimulation includes processes such as increased glucose oxidation, generation and propagation
of action potentials as well as neurotransmitter release. It is important to employ an approach that
is specific to the investigation of excitatory and inhibitory processes involving glutamate and
GABA neurotransmitters, respectively, since the maintenance of the brain’s E/I balance is crucial
for neuronal function (Letzkus, Wolff, & Luthi, 2015; Tatti et al., 2017)). 1H MRS is the only
neuroimaging technique that can non-invasively measure neurometabolite levels; and despite
lacking the spatial resolution of other neuroimaging techniques, can provide valuable
complementary information.
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As an analytical and a quantitative technique, 1H MRS finds wide applications in clinical
as well as research settings. In clinical applications, 1H MRS data are collected during resting
conditions (without any behavioral constraints imposed) and static levels of metabolites are
compared between clinical populations and healthy controls. In research, the technique finds
applications not only in the comparison of static metabolite levels between groups, but
importantly, also in investigating dynamic changes (modulation) in levels of metabolites,
especially neurotransmitters, in response to neural activity. The latter approach that incorporates
sequential acquisition of MR spectra over time, has led to the coining of the term 1H functional
MRS (1H fMRS) to highlight the importance of assessing functional changes in steady-state
metabolite levels (J. A. Stanley & Raz, 2018). Thus, while 1H MRS provides data on static levels
of metabolite, 1H fMRS records data when behavioral constraints are imposed which lead to new
steady states of metabolites in response to the stimulation. These behavioral constraints can be
stimuli such as a fixation cross, a flashing checkerboard, or a cognitive task for instance (Lynn,
Woodcock, Anand, Khatib, & Stanley, 2018). 1H fMRS can thus also provide information about
the temporal change in metabolite levels in the specific ROI. Radiolabeled 13C MRS applications
mentioned briefly in Chapter 1 are a form of fMRS; the only limitation being the requirement of
injecting a radiolabeled ligand, thus, making it an invasive approach.
Recently, 1H fMRS is finding applications in cognitive neuroscience research. The 1H
MRS signal acquired from an ROI during rest (in the absence of any stimulation) reflects the
static levels of the metabolites, including neurotransmitters like glutamate, whose associations
with behavioral perturbations are unclear. However, associations between such static
neurotransmitter levels and cognitive performance have indeed been reported, where cognitive
performance measured outside the scanner was simply correlated with glutamate levels
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(Nikolova, Stark, & Stark, 2017; Spurny et al., 2020; Thielen et al., 2018). Since neuronal
response to any kind of stimulation (sensory, motor, cognitive) involves a constant adjustment of
neurotransmitter levels to maintain the E/I balance (J. A. Stanley & Raz, 2018), assessment of
the temporal dynamics of neurochemical levels is more important than that of static levels. As
previously mentioned, 1H functional MRS (1H fMRS) is the only non-invasive technique that can
measure in vivo glutamate modulation in response to stimulation (motor, sensory, or cognitive)
of a localized region in the brain, with a high temporal resolution that allows tracking of
glutamate levels at a sub-minute time scale. Significant modulation of glutamate in the occipital
cortex upon visual stimulation (Mangia et al., 2007), in the motor cortex during a finger tapping
task (Schaller et al., 2014), in the dorsolateral prefrontal cortex during a working memory task
(Woodcock et al., 2018), and in the hippocampus during an associative memory task (J.A.
Stanley et al., 2017) corroborate the utility of 1H fMRS as a technique to measure modulation of
glutamate in response to stimulation. In fact, the Stanley et al study also demonstrated the
specificity of glutamate modulation to different memory stages, underscoring the ability of 1H
fMRS to capture the temporal behavior of the glutamate signal.
2.4.1 1H MRS in studying aging
1

H MRS has been used to compare metabolite levels in animal models of aging and AD

as well as in human participants. Low medial temporal levels of glutamate have been
demonstrated in rodent models of AD (Febo & Foster, 2016) and in healthy aged rodents (X.
Zhang et al., 2009). Low glutamate and high glutamine levels, leading to a low Glu/Gln ratio,
have been documented in the hippocampi and sensorimotor cortices of aged rats (Harris et al.,
2014). It can be speculated that higher glutamine levels with aging are related to increases in the
number of astrocytes as indicated by age-related increases in myoinositol (a glial marker)
(Kaiser, Schuff, Cashdollar, & Weiner, 2005). In humans, age-related reduction in hippocampal
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and cortical glutamate (Hädel, Wirth, Rapp, Gallinat, & Schubert, 2013) has been reported in
older adults with mild cognitive impairment as well as in those with AD, compared to their
healthy age-matched counterparts (Antuono, Jones, Wang, & Li, 2001; Rupsingh et al., 2011)
(for a review see (Haga, Khor, Farrall, & Wardlaw, 2009)).
Static levels of glutamate measured in the absence of any behavioral constraint have been
associated with age-related differences in cognition and behavior. For instance, the combined
levels of hippocampal glutamate and its precursor and breakdown product - glutamine - have
been linked to out-of-scanner verbal memory performance in healthy old adults (Nikolova et al.,
2017). Low levels of striatal glutamate in the elderly have been associated with poor
performance on a visuomotor task (Zahr et al., 2013). Whereas these and other studies hint at
glutamatergic dysfunction as one of the factors in age-related cognitive decline, they fail to
address the neurotransmitter dynamics taking place during cognitive performance (such as
memory encoding and retrieval) (J.A. Stanley et al., 2017) that may be crucial for pinpointing the
mechanisms of cognitive dysfunction. The current dissertation study aims to fill this gap by
investigating age differences in the temporal dynamics of hippocampal glutamate during
associative memory function using a paradigm adapted from Stanley et al (J.A. Stanley et al.,
2017).
The importance of 1H MRS in studying aging, age-related changes, and age differences in
levels of neurometabolites is underscored by the fact that the signal generated by MRS is not
susceptible to the effects of neurovascular coupling. This is a critical point of comparison to the
most commonly used fMRI BOLD signal, which depends on the contrast generated by cerebral
blood flow and cerebral rate of oxygen metabolism, thus, being dependent on neurovascular
coupling and affected by the aging cerebral vasculature. Functional MRI studies that investigate
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age effects, do so by assuming age-invariant coupling of the neural activity to the BOLD signal.
However, neurovascular coupling changes with age (D'Esposito, Zarahn, Aguirre, & Rypma,
1999) owing to age differences in the vascular reactivity, elasticity, and other characteristics of
the vascular bed as well as age-related increases in vascular pathology. The BOLD response is
confounded by such events and, thus, its interpretation when assessing age effects might not
reflect true changes in brain activity or metabolism (D'Esposito, Deouell, & Gazzaley, 2003). In
contrast, 1H MRS provides direct information about the levels and changes in neurochemicals
(including excitatory and inhibitory neurotransmitters such as glutamate and GABA) involved in
neurotransmission and metabolism, providing an avenue to assess the functional changes in the
brain (J. A. Stanley & Raz, 2018).
2.5 What does the 1H fMRS signal mean?
One would like to believe that the changes in glutamate levels observed using 1H fMRS
reflect the increase in glutamate released in the synapse. However, owing to poor spatial
resolution, 1H fMRS quantifies metabolites in the entire tissue rather than at the finer cellular
level. 1H fMRS cannot distinguish between the compartments that the signal arises from and is
assumed to capture the glutamate signal from all cellular compartments (neurons, glia, synaptic
cleft, presynaptic vesicles) in the ROI. Task-related modulation of glutamate levels, thus, reflects
the net change in glutamate within the chosen voxel.
It is unlikely that the signal measured by fMRS reflects synaptic glutamate molecules
involved in neurotransmission. The overwhelming majority of glutamate is intracellular – about
10 mM, compared to only 0.5 - 1.0 μM extracellular glutamate (Erecinska & Silver, 1990). In
addition, the timescale of synaptic glutamate turnover is very brief with glutamate staying in the
synaptic cleft for less than 5 ms before binding to post-synaptic receptors or transporters
(Clements, Lester, Tong, Jahr, & Westbrook, 1992). Thus, 1H fMRS measures glutamate that is
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almost exclusively located inside the cells and nearly all the changes observed in glutamate are
assumed to have a metabolic basis. This is congruent with the 1:1 stoichiometry between
neuronal glucose oxidative metabolism (TCA cycle) and the glutamate-glutamine cycle of
neurotransmission, where each molecule of glutamate recycled requires the oxidation of one
molecule of glucose (see Chapter 1). This indicates that the metabolic and neurotransmitter
pools of glutamate are closely linked and are indistinguishable by 1H MRS.
Glutamate levels in a cortical region (or a specific voxel), and task-induced changes
therein, as quantified by the 1H MRS signal reflect the net E/I status of that region. An increase
in glutamate during stimulation indicates more excitability, whereas glutamate reduction
indicates a gradual decrease in excitability or a gradual increase towards the inhibitory drive.
Although 1H fMRS at 3T cannot measure GABA reliably, it is important to remember that the
two neurotransmitter systems are highly integrated in neuronal ensembles and respond to
stimulation by driving the shift in the brain’s E/I balance. The dynamic equilibrium of excitation
and inhibition always strives to maintain the E/I balance in the brain to give rise to new
metabolic states required to meet task demands.
2.6 Limitations of single voxel MRS
The SNR for MRS studies depends on the voxel size due to low concentrations of the
metabolites within the voxel. However, large voxels bring with them the problem of partial
volume, where data are collected from surrounding tissue that might be inactive. In addition,
since only one ROI can be studied at a time, neurochemical changes occurring in other regions
involved in stimulus processing cannot be captured simultaneously. For instance, as described in
Chapter 1, memory function involves not only the hippocampus, but also the association cortices
such as the prefrontal cortex; and these neural correlates might be differentially involved during
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the various stages of memory function. Single voxel MRS precludes the simultaneous
investigation of neurochemical changes in these regions during memory performance.
Signal averaging, an integral part of MRS data acquisition, ensures higher SNR but
lengthens the experimental time, thereby increasing the risk of participant fatigue and loss of
attention. This can affect the true change in neurochemistry observed. The high sensitivity of the
MRS signal to magnetic field inhomogeneity makes shimming an essential part of data
acquisition. Shimming can further lengthen the experiment time in challenging situations such as
aging research where ROIs have undergone atrophy or have high iron accumulation (J. A.
Stanley & Raz, 2018).
An important thing to note while interpreting the effect size of MRS data is the wide
range of changes in levels of glutamate observed upon neuronal activation. The observed
glutamate levels depend on numerous aspects of the study design: block vs event-related design,
type of stimulus, region being investigated, to name a few (for a summary of studies with stimuli
used and effect size observed see (Lynn et al., 2018)). Noxious as well as visual stimuli tend to
elicit larger changes in glutamate levels compared to cognitive stimuli, where changes can also
range from 2.6% to 12% depending on the paradigm used and the region studied (Mullins,
2018). This discrepancy has been interpreted as, a more salient stimulus eliciting a larger
glutamate response. The mean change in glutamate, aggregated from studies using various
stimulus paradigms, ROIs, field strengths and so on, is about 7% (Mullins, 2018). The expected
optimal effect size with MRS research, thus, remains an open question.
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METHODS
3.1 Power Analysis
I based the power analysis on a previous study that compared age differences in
hippocampal glutamate levels measured during rest (Kaiser et al., 2005) as well as a study by our
group that characterized hippocampal glutamate modulation during associative memory function
in young adults (J.A. Stanley et al., 2017). G*Power version 3.1 was used to conduct power
analysis.
3.1.1 Age-related difference in levels of hippocampal glutamate measured during a control
condition
In a study by Kaiser et al, young participants (n = 11) had 13% (1.24 mM/kg.w.w.) more
glutamate in their motor cortices than the old (n = 13) with a standard deviation of 0.863
(Cohen’s d = 1.44) (Kaiser et al., 2005). For the current study, assuming age differences in
hippocampal glutamate levels to be at least half as much as in the Kaiser et al study, i.e. 0.62
mM/kg.w.w, and a medium to large effect size (Cohen’s d = 0.70), a total sample size of 68 (34
in each group) was required to achieve 80% power for a two-sided t test for independent groups.
3.1.2 Age-related difference in hippocampal glutamate modulation during associative learning
and memory
A previous study in our lab (J.A. Stanley et al., 2017) utilizing the object-location
associative learning and memory task in healthy young participants observed mean hippocampal
glutamate levels of 13.4 mM/kg.w.w., and about 11% and 7.7% task-related increases in
glutamate in fast and slow learners, respectively. In the current study on age differences, the
primary dependent variable in the repeated measures analysis was glutamate level, with controllevel glutamate as the continuous covariate, and age group as the between-subject categorical
variable. To improve the SNR of the hippocampal glutamate signal three consecutive blocks out
of the 12 encoding blocks were averaged to give four measures for encoding. A similar
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averaging approach was applied to the retrieval blocks. This created four block triads per task
stage. Refer to Figure 8 for a schematic of the averaging approach. The averaging approach was
analogous to the one used in the previous study (J.A. Stanley et al., 2017). The within-subject
factors were task stage (encoding, retrieval) and block triad number (1-4). For a between-within
interactions repeated measures GLM analysis assuming a small to medium effect size f = 0.2,
Bonferroni corrected type I error rate = 0.006, the sample size required to achieve 80% power
was 56 (i.e. 28 per age group). Based on the analysis in 3.1.1 and allowing for possible attrition
and exclusions, I decided to recruit a total sample of 72, with equal numbers of young and old
adults.
3.2 Participants
Participants for this study were recruited through the Wayne State University online
advertising system, flyers distributed across the campus, and word-of-mouth referrals. Note that
this study was conducted on a sample of convenience that is unlikely to represent the general
population of young and old adults. One hundred and four people responded to the
advertisements and called the lab for additional information about the study. Twenty-five people
were excluded based on an initial screening conducted via a telephone interview. All eligible
participants at this stage completed an additional and detailed health questionnaire to screen for
history or current diagnosis of neurological and psychiatric disorders, cardio- and cerebrovascular disease, endocrine disorders, diabetes, cancer, head trauma with loss of consciousness
for more than five minutes, and claustrophobia. Additional exclusion criteria were: recreational
drug and alcohol abuse and treatment thereof, alcohol consumption (excess of three drinks per
day), and history or current use of anxiolytics and antidepressants. Pregnant and lactating
women, as well as those with intrauterine contraceptives were excluded from the study.
Participants diagnosed with hypertension and taking anti-hypertensive medications were
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included in this study, as were those who reported treatment for abnormal levels of thyroid
hormones. In addition, the participants underwent standard metal screening. All participants were
right-handed (scores over 75% on the Edinburgh Handedness Questionnaire) (Oldfield, 1971)
and completed the Center for Epidemiologic Studies questionnaire to rule out current depression
(CES-D; cut-off = 15) (Radloff, 1977).
After the extensive health screening, 61 participants were deemed eligible and provided
informed consent in accordance with the Wayne State University Institutional Review Board
guidelines. Cognitive impairment was screened for by using the Mini Mental State Examination
(MMSE; cut-off = 27) (Folstein, Folstein, & McHugh, 1975). Every participant’s systolic and
diastolic blood pressure was measured at the beginning of the session via an aneroid
sphygmomanometer (MDF Calibra) with a standard blood pressure cuff on the left arm with the
participant seated in a comfortable position. The sample was on average normotensive, defined
as having blood pressure below 140 mm Hg systolic and 90 mm Hg diastolic. Vision correction
was provided to participants in need using MRI compatible glasses and lenses that matched their
prescription. Once the participant was inside the scanner, and before scanning commenced,
sample images and instructions were displayed, and participants’ accurate identification thereof
was confirmed to ascertain vision correction.
As depicted in Figure 4, out of the 61 participants scanned, two were excluded from
analyses because of incidental findings such as arachnoid cysts, and nine (five young and four
old) were excluded owing to poor data quality due to head motion. In this study, for glutamate
spectra collected from the hippocampus, the CRLB value was set to 16% (J.A. Stanley et al.,
2017) and the block triads with higher CRLB values were excluded. An additional four
participants (one young and three old), who had one of the four block triads excluded due to high
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CRLB values, were omitted from data analysis. Note that this was a more stringent criterion
employed in the current study, whereas other groups exclude only individual poor spectra.

Figure 4. Participant recruitment flow chart.

The sample analyzed here, thus, consisted of 46 participants including 32 healthy young
(21 to 30 years, M = 25.37, SD = 2.9, 16 women) and 14 healthy old (60 to 70 years, M = 65.25,
SD = 3.2, 8 women) adults. Descriptive demographic statistics of the sample are listed in Table
2. Note: The recruitment occurred during the years 2018, 2019, and 2020 but was not completed
because of the COVID-19 pandemic, with ensuing restrictions preventing additional accrual of
the sample; hence the lack of balance between the two age groups.
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Table 2. Demographic profile of the final sample analyzed. Values indicate mean ± 1
standard deviation
t

χ2

p

25.37 ± 2.9

-

-

-

57%

50%

-

0.19

0.65

85%

55%

-

6.78

< 0.05

Average education (years)

18.2 ± 1.7

16.6 ± 1.6

<1

-

0.9

Average MMSE

29.3 ± 0.7

29.2 ± 0.9

0.18

-

0.86

Average systolic BP (mm/Hg)

125.8 ± 10.4

116.4 ± 7.9

3.65

-

< 0.005

Average diastolic BP (mm/Hg)

83.1 ± 8.4

77 ± 6.7

3.06

-

< 0.005

Old

Young

14

32

Age (years)

65.25 ± 3.2

% Women
% Caucasian

N

Note: MMSE = Mini Mental State Examination, BP = Blood Pressure
3.3 Associative learning and memory task
The object-location paired-associates task used in this study was adapted and modified
from a human analogue of spatial tasks in animal studies of hippocampal associative learning
(Diwadkar et al., 2008). Previous studies have shown that this task produces hippocampal
glutamate modulation that demonstrates unique temporal dynamics during memory encoding and
retrieval (J.A. Stanley et al., 2017). Before the MRS study, I conducted a pilot study in a mock
MRI scanner, to modify and optimize the original associative memory task. The modifications
sought to allow more time for learning to occur in both age groups, and to help choose the level
of task difficulty that minimizes celling effects while demonstrating group differences.
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3.3.1 Piloting of the object-location associative learning and memory task
A separate pool of participants was recruited for this task optimization study via listservs
and flyers posted across the Wayne State University campus, and the sample included twenty
young (21-30 years, M = 23.7, SD = 2.4, 12 women) and eight old (60-70 years, M = 64.6, SD =
2.2, 5 women) adults who met the inclusion and exclusion criteria previously mentioned.
The original associative memory task ((Diwadkar et al., 2008; Wadehra, Pruitt, Murphy,
& Diwadkar, 2013), also employed in (J.A. Stanley et al., 2017)) consisted of alternating blocks
of memory encoding and retrieval. During encoding, black and white line drawings of nine
unique and familiar objects were presented one at a time in each of the nine squares of a 3  3
grid. The objects were chosen from the Snodgrass and Vanderwart line-drawings set and
familiarity was equalized among them based on the reported norms (Snodgrass & Vanderwart,
1980). During the encoding stage that was 27 seconds long each of the nine objects was
presented for 3 seconds in its unique location on the grid. During the retrieval stage (also 27
seconds long), instead of the object, a black square was presented once in each of the nine
locations and served as a cue for the participant to recall the object that was earlier presented in
the cued location. Cued recall was chosen instead of free recall, because it imposes stronger
demands on the associative memory network (Kan, Giovanello, Schnyer, Makris, & Verfaellie,
2007). Participants vocalized their responses during encoding and retrieval and were instructed
to choose monosyllabic names for the objects to reduce head motion. If unable to recall the
object or make their best guess about what the object might be, participants were instructed to
say “no”. A ‘non-zero’ response meant vocalizing a correct answer, an incorrect answer, or
saying “no” as instructed. All responses were scored in real-time as well as audio-recorded so
that the score could be checked against the recorded responses. Each encoding and retrieval stage
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was followed by a rest period of 27 seconds, where participants were instructed to focus on a
fixation-cross presented on the screen. Blocks of encoding-rest-retrieval-rest made up one epoch,
and eight such epochs were presented. The object-location associations remained constant;
however, the order of presentation of objects and cues was random (Figure 5).

Figure 5. A schematic depicting the original 3 × 3 object-location paired-associates task
(Diwadkar et al., 2008). Encoding-rest-retrieval-rest made up one epoch and eight such epochs
were presented as a part of the task.

The following modifications were made to the above-described task for piloting:
(i)

Blocking of memory rehearsal. The passive rest period after each encoding and
retrieval block was replaced with a block of counting backwards by one, from a
randomly chosen number between 40 and 80, programmed into the task.
Participants were instructed to count aloud backwards for 20 seconds at a calm
and steady pace of one number per second. The purpose of the counting task was
to provide articulatory suppression (Baddeley & Hitch, 1974; Salamé &
Baddeley, 1989) and prevent active rehearsal during memory maintenance;
especially since encoding and retrieval required articulation of the responses, and
also to remove potential variability among subjects in memory rehearsal and use
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of strategies. In addition, this also ensured that all participants performed a
controlled mental activity during memory maintenance.
(ii)

Task-length. The task was lengthened by extending it from eight to 12 epochs to
provide more opportunity for older adults to reach an asymptote.

Figure 6. Mock MRI scanner used to simulate the MR environment.

This pilot study was conducted in an adult-size mock MRI scanner that is routinely used
for preparing patients for real imaging procedures (Figure 6). It mimics the actual MRI scanner
environment, including the bed, the magnet housing, and the head-coil frame. A laptop
displaying the associative memory task depicted in Figure 5 was placed behind the bore of the
mock scanner to project the stimuli on to a mirror attached to the mock head-coil. To simulate
the scanner noise, a pre-recorded 1H MRS sequence, recorded during a phantom scan in a real
scanner, was played throughout the mock-scanning session from speakers located behind the
bore of the mock scanner. I added the mock-scanner condition to the pilot study to include an
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exploratory analysis of the effects of the MR-scanner environment on performance of the
memory task, since little attention has been paid to this aspect of lab-based cognitive testing.
There are substantial differences between conventional cognitive testing procedures and
their implementation in the MRI scanner, including a noisy environment, supine position, and
tight quarters, to name a few. All these factors may affect cognitive performance by adding stress
and distraction from the task (Kobald, Getzmann, Beste, & Wascher, 2016). To date, the effects
of MRI scanner environment on cognitive performance have been examined in a handful of
studies and almost always in research designs that focused on one factor at a time (Jacob et al.,
2015; Kobald et al., 2016; Koch et al., 2003), without assessing the effect of interactions among
factors. Since it is possible that these factors act in concert instead of in isolation, a study-design
that includes a combination of two or more of them is more appropriate. As illustrated in the
schematic in Figure 7, the effects of a within-subject variable ‘setting’ (task performed while
seated at a desk or while lying supine inside the mock MRI scanner) and a between-subject
variable ‘noise’ (presence or absence of simulated MRI scanner noise) on associative memory
performance were compared between the two age groups. Participants were asked to lie down on
the scanner table with their head placed inside the bore. As is typical in an actual MRI protocol,
participants’ heads were supported by padding to prevent sudden movements. Participants were
explicitly told that the experiment is conducted in a mock scanner, as the absence of a real
magnetic field does not affect behavior (van Maanen, Forstmann, Keuken, Wagenmakers, &
Heathcote, 2016); and the mock environment is associated with equal levels of anxiety
(McGlynn, Smitherman, Hammel, & Lazarte, 2007) and stress (Lueken, Muehlhan, Evens,
Wittchen, & Kirschbaum, 2012) as in the real scanner. In each experimental condition (at the
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desk and in the mock scanner), participants performed 12 epochs of encoding-counting-retrievalcounting. The entire session, including consenting and screening, lasted approximately 1.5 hours.

Figure 7. Schematic of the mock-scanner pilot study design.

(iii)

Task-complexity. Ceiling effects were noted in the modified version of the task,
with 100% asymptotes achieved by several participants despite blocking memory
rehearsal. The task-complexity was, therefore, increased to allow age differences
in performance while avoiding ceiling effects. The optimal level of taskcomplexity would induce the least amount of boredom (due to the task being too
easy) and frustration (due to the task being too difficult), but at the same time
would allow learning to gradually occur. Two versions of the original task with
different levels of difficulty - (a) grid size: 3  4 (12 objects, 2.67 seconds per
object) and (b) grid size: 4  4 (16 objects, 2 seconds per object) were created and
characterized. The duration of each retrieval cue during the two complex tasks
matched that of object presentation, respectively. Both versions of the task
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included 12 epochs of encoding-counting-retrieval-counting and were performed
only in the scanner in the presence of noise.
3.3.2 Final object-location associative learning and memory task
For the dissertation study investigating age differences in hippocampal glutamate
modulation during associative memory, I chose the 3 × 4 grid version of the task with 12 epochs
of encoding-counting-retrieval-counting. Task-related changes in levels of glutamate are
normally compared to those obtained during a control condition. While the cognitive task is
intended to modulate glutamate levels during performance, the control condition is expected to
provide steady-state and less variable measures thereof. The most commonly used control
conditions are fixation cross and flashing checkerboard, with some studies utilizing simple eyesopen or eyes-closed conditions (Lynn et al., 2018). The steady-state glutamate levels, and
variability therein, depend on the control condition chosen.
For the current study, the associative memory task was preceded by a fixation cross (5:26
min) followed by a 2-Hz flashing checkerboard (5:26 min). These two conditions served as taskfree and non-hippocampal control conditions for assessing the steady-state, control levels of
hippocampal glutamate between the age groups. Inside the scanner, participants viewed the
fixation cross followed by the checkerboard projected from a monitor on to the mirror attached
to the head coil. While viewing, they were instructed to not think of anything specific and let
their mind wander.
The schematic task representation (Figure 8) depicts the relevant conditions and the time
course of a trial within the associative memory task. The associative memory task was
programmed using Neurobehavioral systems Presentation software (version 17) and lasted for
19:12 minutes. At the encoding stage, participants viewed a 3  4 grid projected from a monitor
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on to the mirror attached to the head coil. In each of the 12 squares of the grid, a unique object
appeared one at a time, and stayed in its location for 2.67 seconds before the next object
appeared in its unique location. The objects appeared in their locations at random.
Randomization of occurrence precluded primacy or recency effects that would be brought about
by presentation of the objects in any specific order. Each encoding block lasted about 32.04
seconds (2.67 seconds per object, 12 objects). As in the pilot study, objects came from the
Snodgrass and Vanderwart line-drawings set (Snodgrass & Vanderwart, 1980). Participants
responded by vocalizing the name of the object and were instructed to choose monosyllabic
words for the object names in order to reduce head motion inside the scanner.
The memory retrieval stage lasted 32.04 seconds and included presentation of the same 3
 4 grid. However, instead of objects, a black square appeared once in the location on the grid
where the object appeared at encoding. It served as a cue for the participant to recall and vocalize
the name of the object that they had seen during the encoding stage. The black square stayed on
for 2.67 seconds before the next one appeared in a randomly chosen location that was occupied
by a different object during the encoding stage. If unable to recall the object or make their best
guess about what the object might be, participants were instructed to say “no”. A ‘non-zero’
response meant vocalizing a correct answer, an incorrect answer, or saying “no” as instructed.
All responses were scored in real-time as well as audio-recorded so that the score could be
checked against the recorded responses.
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Figure 8. Object-location associative learning and memory task. The top panel shows a
schematic of the 3 × 4 object-location paired-associates task. The bottom panel shows the
playout of the task with each epoch made up of blocks of encoding (E) -counting (C) - retrieval
(R) - counting (C). The entire task consisted of 12 such epochs.

As in the pilot study, each encoding and retrieval stage was followed by a buffer task, in
which the participants counted aloud backwards by one from a random number between 40 and
80, chosen by the randomization programmed in the task. Each counting condition lasted 16.02
seconds. Participants were instructed to count at a calm and steady pace of one number per
second. The purpose of the buffer task was to engage all participants in a uniform controlled
activity designed to suppress the articulatory loop (Baddeley & Hitch, 1974; Salamé &
Baddeley, 1989), prevent active rehearsal during the memory maintenance interval between
encoding and retrieval, and suppress use of strategies. In addition, this also ensured that all
participants performed a controlled mental activity during memory maintenance. Learning of the
object–location association pairs was assessed over 12 encoding-counting-retrieval-counting
epochs. Prior to scanning, each participant received detailed instructions regarding the
associative memory task and practiced for one trial of encoding, counting, and retrieval on a
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laptop outside the scanner. The goal of this short demonstration was to familiarize the participant
with the task format before performing it in the scanner. During this one trial, the timing of
presentations of objects and cues matched those of the in-scanner task to familiarize the
participant with the presentation speed.
At the end of the task, when the participant stepped out of the scanner and was back in
the control room, a cognitive test assessing free recall of the objects was conducted. The
participant was provided with a sheet of paper with the 3 × 4 grid drawn on it. They were
instructed to visualize the objects that were presented to them on the grid while performing the
in-scanner task and write the object names in the appropriate location on the grid drawn on the
paper. This was a single trial test with no time limit or recall order imposed on the participant.
3.4 Neuroimaging protocol
As detailed in the neuroimaging protocol below, 1H MRS spectra were continuously
collected when the participants performed the task inside the scanner.
3.4.1 Signal acquisition
All imaging was performed on a 3 Tesla (3T) MRI system (Siemens MAGNETOM
VerioTM) with a 32-channel receive-only head coil. All scans were collected in the morning
between 9:00 am and noon to standardize the time of scanning, and the imaging protocol was
identical for each participant. A scout image (TA = 9.2 sec) was followed by a structural T1
MPRAGE scan collected in the axial plane. The T1 MPRAGE covered the whole brain and had a
resolution of 1  1  1 mm3 with the following parameters: TR = 2.15 sec, TE = 3.53 ms, TI =
1100 ms, GRAPPA = 2, flip-angle = 80, FOV = 256 × 256 × 160 mm3, 160 axial slices, pixel
resolution = 1 × 1 × 1 mm3, acquisition time = 4:59 min.
To proceed with 1H MRS scans, a 3.0 × 1.8 × 1.3 cm3 (7.02 cm3) voxel was prescribed in
the unilateral (side randomized) anterior hippocampus of the participant (Figure 9). Hippocampal
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side was randomized across participants because of the nature of the associative memory task
used in this study. The task included aspects of spatial, visual, as well as verbal memory owing
to object-location associations that had to be encoded and retrieved via vocalization. The right
hippocampus in involved in spatial memory, whereas the left in verbal memory (Ezzati et al.,
2016; Kelley et al., 1998). Owing to possible individual variability in utilizing these domains, an
effect of hemispheric differences on hippocampal glutamate levels was not hypothesized. The
anterior hippocampus was chosen because of its involvement in spatial and associative memory
(Schacter & Wagner, 1999). Hippocampal voxel was manually placed for each participant’s
scan. Prior to the 1H MRS acquisition homogeneity of the magnetic field in the hippocampal
voxel was optimized (shimmed) using FASTESTMAP (Tkáć & Gruetter, 2005). Before the
beginning of the MRS sequence, a trigger-pulse time-locked the presentation of the stimulus with
the acquisition of the spectra. The 1H MRS scans were acquired using the point-resolved
spectroscopy (PRESS) sequence with outer volume saturation (OVS) for improved localization
and reduced signal contamination from outside the hippocampal voxel, high bandwidth sliceselective RF pulses for minimal chemical shift displacement, and VAPOR for water suppression
and a clean spectral baseline. The 1H MRS scans were continuously acquired approximately
every 16 seconds as the participants performed the task. For the control conditions (fixation cross
and flashing checkerboard) and the task with 12 sets of encoding-counting-retrieval-counting
epochs, the acquisition parameters were as follows: TR = 2.67 sec, TE = 23 ms, 6
averages/spectrum, bandwidth = 2 kHz, 2048 complex data points.
Twenty 1H MRS spectra were collected during each of the control conditions (fixation
cross and flashing checkerboard). Seventy-two spectra were collected during the associative
memory task. Each spectrum indicated a single measurement comprising of 6 averages, totaling
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16.02 sec per averaged spectrum. Thus, per encoding and retrieval block, each of which were
32.04 seconds long, there were two measurements (16.02 + 16.02 sec) or two averaged spectra.
The 16.02-second-long counting condition comprised of only one measurement or one averaged
spectrum. A fully relaxed water-unsuppressed spectrum (TR = 10 sec, TE = 23 ms, 2 averages)
was acquired from the same voxel as part of the absolute quantification approach. These waterunsuppressed spectra were acquired after the fixation cross condition and after the checkerboard
+ associative learning task condition to be used as an internal reference for the quantification of
MRS data.
3.4.2 Image post-processing and quantification of the spectra
Prior to quantification, each spectrum was frequency- and phase-corrected. Eddy current
effects were corrected using the unsuppressed water signal (Klose, 1990). FreeSurfer and FSL
tools were used to correct the B1 field, extract images, segment into tissue volume maps (CSF,
gray and white matter), and estimate the tissue fractions within each voxel (Jenkinson,
Beckmann, Behrens, Woolrich, & Smith, 2012). The water-unsuppressed signal, gray and white
matter, and CSF values from the tissue segmentation procedure (FAST) (Y. Zhang, Brady, &
Smith, 2001), along with T1 and T2 relaxation values, were used to quantify absolute values of
the neurometabolites (mmol/kg.w.w) (Gasparovic, 2006; J. A. Stanley et al., 1995).
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Figure 9. An example 1H MRS spectrum. Acquired (black) and modeled (red) in vivo 1H MRS
spectrum from the right hippocampus (96 sec temporal resolution). Raw (black line) and
LCModel fit (red line) signal are displayed above the estimated spectral peaks for Glu (blue
line). The residual signal (i.e. noise) and chemical shift (ppm) are displayed at the bottom of the
figure. The panel on the right side shows from top to bottom: sagittal, coronal, and axial views of
the MRS voxel placed in the head/body of the hippocampus.

The ¹H fMRS acquisition in the hippocampus had a temporal resolution of 16.02 seconds.
Thus, each encoding and retrieval block contained two measures (2  16.02 = 32.04) and the two
counting conditions were one measure each (16.02 seconds). However, the SNR in the
hippocampus was very low and prompted combining the signal from three (spectral tripling)
consecutive encoding blocks (2 spectra per block), with a similar combination scheme applied to
retrieval blocks. Spectral averaging was performed after phase and frequency correction of
individual spectra and this improved the SNR from 4 ± 0.75 to 9.04 ± 1.65. This resulted in a
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series of four outcome measures for each stage, giving a temporal resolution of 96 sec.
Averaging fewer blocks would have improved the temporal resolution while sacrificing SNR.
Thus, even though spectral tripling afforded only four total time points per memory stage, the
more-than-doubled SNR ensured greater confidence in the signal.
Completely automated post-processing of

1

H fMRS data and quantification of

neurometabolites was performed using Linear Combination (LC) Model (version 6.3) with a
simulated basis-set for a priori knowledge (Provencher, 1993). The first spectrum from the
fixation cross and checkerboard conditions, each, was excluded from analysis due to a possible
T1-saturation effect (De Graaf, 2013). Spectral fitting was assessed via the Cramér-Rao lower
bound (CRLB) value. It is the threshold of the error associated with model fitting and reveals
uncertainties in the fit i.e. the difference between acquired and modeled spectra (Cavassila et al.,
2001). Spectra with CRLB values higher than a certain threshold indicate less reliable measures
and are characterized by less optimal peak separation as well as more noise in the fitting. Higher
CRLB values are associated with low SNR, low glutamate, and high FWHM. Spectra with high
CRLB values are commonly excluded from further analyses. For the current study, the CRLB
was set at a threshold of 16% for hippocampal glutamate (J.A. Stanley et al., 2017) and spectral
triplets with CRLB values more than 16% were discarded since that indicated an unacceptable fit
in LCModel. An example of a 1H MRS spectrum obtained from the right hippocampus is shown
in Figure 9 above.
Although the focus of the current investigation was glutamate, levels and dynamics of
GABA, the major inhibitory neurotransmitter, are an important subject of inquiry as well. Both,
glutamate and GABA, play a collaborative role in maintaining the brain’s E/I balance. However,
reliable quantification of GABA requires possibly higher magnetic field strength as well as
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special spectral editing techniques that can resolve the GABA resonance (Rothman, Petroff,
Behar, & Mattson, 1993). Thus, only data on glutamate analyses are reported.
3.5 Modeling of behavioral data
Each participant’s behavioral data were collected during the cued-retrieval stage of the
associative learning and memory task and were expressed as percent correct responses out of a
maximum of 12 per block of retrieval. Considering the individual variability in the behavioral
data, it is critical to choose an optimal model function to fit the data and characterize the learning
curve. Model fitting was evaluated for five different functions commonly mentioned in literature:
single-parameter linear and negatively accelerating exponential functions that optimize the slope,
three-parameter logistic and Gompertz functions that optimize the asymptote, inflection point
and slope, and four-parameter Richards function that optimizes an additional parameter called
shape. The linear and negatively accelerating exponential functions did not capture the learning
behavior and did not allow for individual variability in the learning curves. In addition, these
functions also demonstrated weaker goodness of fit. Both the three-parameter functions, logistic
and Gompertz, were equally suitable for these data. Such three-parameter families of curves
(Vieira & Hoffman, 1977), and more so, the Gompertz function, have been extensively used for
modeling growth data (Winsor, 1932). The Gompertz function is a special case of the logistic
function where the inflection point is at 37% of the upper asymptote, instead of at 50%, thus,
making the former more asymmetric. Most growth processes are not symmetric around the
inflection point (Vieira & Hoffman, 1977), and in line with that property, in our data, with a
maximum of 12 objects, learning seemed to occur earlier in the task. Learning rates in most
participants were higher initially and later gradually decreased as performance approached the
asymptote, indicating an asymmetrical ‘S’ shaped learning curve. Although, the four-parameter
Richards function can flexibly accommodate different growth patterns owing to the shape
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parameter (Birch, 1999), a criticism about this function is the lack of interpretability of the shape
parameter (Zwietering, Jongenburger, Rombouts, & van 't Riet, 1990).
Goodness of fit measures (χ2, R2, and RMSE) were compared among all five fits. The
Gompertz and Richards functions, both, fit the data well. However, a model that optimally
describes the data using fewer parameters is recommended over a model with additional
parameters. The three-parameter model is conceptually simpler than the four-parameter model
and its solution is more stable since the parameters are less correlated. I, therefore, selected the
Gompertz function to fit the learning data (Gompertz, 1825; Zwietering et al., 1990). The
Gompertz function optimized three parameters that are expected to capture the salient
characteristics of the learning process in each individual: asymptote (maximum attained score
reflecting the associative learning proficiency), slope (learning rate), and point of inflection
(transition from steeper to shallower slope in growth and learning curve models). The Gompertz
function is given as:
y = ae−e (−

t−c
)
r

(5)

where a = asymptote, t = time (block), r = slope (learning rate), c = inflection point
(displacement about the x-axis indicating the block when learning rate transitions from fast to
slower). The curve fitting was implemented in Matlab (MathWorks, 2013), using the lsqnonlin
function.
With respect to data on the single trial free-recall test conducted after the scanning
session, the performance was scored as the number of correct object-location associations
recalled out of total 12. Only accurate object-location pairs were scored as correct responses.
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3.6 Statistical Analyses
3.6.1 Mock scanner pilot study
The data were analyzed using a GLM approach with age group (young, old), location
(scanner, desk), noise (present, absent) as categorical two-level independent variables, and a
vector of the Gompertz learning curve parameters (asymptote, learning rate, and inflection point)
as the dependent variable. For assessing the effects of task complexity, the predictors of
performance were age group and grid size.
3.6.2 Associative learning and memory dissertation study
3.6.2.1 Cognitive data analyses.
The vector of Gompertz function parameters served as the dependent variable, with age
group (young, old) and sex (male, female) being the categorical two-level independent variables.
A GLM analysis assessed the age and sex differences in the Gompertz function parameters.
Correlation analyses evaluated the strength of associations between the free recall score and each
of the learning curve parameters.
3.6.2.2 Glutamate level analyses.
Glutamate levels used in these analyses are absolute levels and not ratios to total creatine,
as are reported in most studies. Age differences in mean levels of glutamate achieved throughout
the encoding, retrieval, and the control conditions were evaluated using the GLM approach. Age
group (young, old), sex (male, female), and hippocampal side (left, right) were the betweensubject factors, whereas task stage (encoding, retrieval, control condition) was the within-subject
factor. Age differences in hippocampal glutamate modulation were investigated via GLM
repeated measures ANOVA (using PROC MIXED in SAS). Glutamate level served as the
dependent variable, with age group (young, old), sex (male, female), hippocampal side (left,
right) as between-subject factors. Task stage (encoding, retrieval) and block triad (1-4) were the
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within-subject factors. Glutamate levels during the control condition, centered at the sample
mean, served as a continuous covariate. Huynh-Feldt correction was applied to account for
violation of the assumption of sphericity in tests of interactions. If a significant age group × task
stage × block interaction was found, it was followed by assessment of the task stage where the
age group × block was the interaction of interest. Further post-hoc analyses were conducted to
determine the block at which age differences were significant. In addition, the effect of block
triad within each task stage was assessed for each age group to examine significant glutamate
modulation.
A variable called ‘adjusted-glutamate’ was calculated, where task-related levels of
glutamate at each block triad were adjusted for mean levels of glutamate during the control
checkerboard condition via analysis of covariance adjustment (Jack et al., 1989). The adjusted
values are calculated as:
𝐺𝑙𝑢𝑎𝑑𝑗 = 𝐺𝑙𝑢𝑜𝑏𝑠 − 𝛽[𝐺𝑙𝑢𝑐𝑜𝑛 − 𝑚𝑒𝑎𝑛(𝐺𝑙𝑢𝑚𝑒𝑎𝑛_𝑐𝑜𝑛 )]

(6)

where, Gluadj and Gluobs are the adjusted and observed concentrations of glutamate in a
participant, Glucon is the participant’s control-level glutamate, Glumean_con is the average controllevel glutamate across all participants, and β is the unstandardized regression coefficient. As the
relationship between control-levels of glutamate and glutamate at each block triad for each task
stage did not differ between the age groups (all control-level glutamate × age group interactions
were non-significant), the same control-glutamate correction was applied to the entire sample.
This correction reduces any bias due to individual differences in control-levels of glutamate.
‘Adjusted-glutamate’ was used only for visualization of the results (i.e. Figure 13).
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3.6.2.3 Relationship between glutamate and cognitive performance.
GLM analyses with age group and control-level glutamate as predictors were conducted
on the Gompertz function parameters to investigate whether age differences in control-level
glutamate affected memory performance. To investigate the relationship between glutamate
modulation and memory performance, two glutamate modulation parameters were defined for
each participant: the maximum level of glutamate achieved during encoding (called ‘Glu-max’)
and the block triad at which Glu-max was achieved (called ‘block-max’). A GLM analysis was
then conducted with a multivariate vector of the three Gompertz function parameters as the
dependent variable. Age group (young, old), sex (male, female), and block-max were the
independent variables. Correlation analyses evaluated the strength of associations between the
free recall score and control-level glutamate as well as between free-recall score and Glu-max.
3.6.2.4 Neurochemical specificity.
Age differences as well task-specific temporal differences were investigated for the other
well-resolved main 1H MRS visible metabolites (NAA, PCr+Cr, GPC+PC, myoinositol) to
confirm neurochemical specificity of the associative memory paradigm with respect to
glutamate.
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RESULTS
4.1 Mock scanner study
Gompertz function showed successful fit (average R2 of 0.98) for cognitive data in both
age groups and for both conditions (desk, scanner). Compliance with task instructions was high,
with about 93% non-zero responses across the entire sample. Overall, the young performed
better than the old and had a significantly higher asymptote: F (1, 26) = 7.45, p = 0.011. With
respect to setting, a trend was noted for older adults to have a lower asymptote than the young
when the task was performed inside the scanner compared to at the desk: F (1, 50) = 4.04, p =
0.055. Simulated MRI noise did not affect performance in either age group. Ceiling effects were
observed for performance in the 3 × 3 version of the grid, with 12 out of the 20 young and five
out of the eight old adults achieving 100% asymptotes. Task complexity was, therefore,
increased in a dose-response manner using 3 × 4 and 4 × 4 grid versions of the task. In a separate
group of participants that were tested for effects of task complexity operationalized as grid size,
it was noted that the 4 × 4 grid significantly and adversely affected learning rate [F (1,11) =
12.69, p = 0.016] and inflection point [F (1,11) = 40.29, p = 0.001]. Thus, the less complex 3 × 4
grid was chosen for the final associative memory task used in the dissertation (see Methods
section 3.3.2); and all following results - behavioral and neuroimaging - are based on data
collected using the 3 × 4 grid version of the task.
4.2 Age differences in associative learning and memory performance in the dissertation
study
The Gompertz function showed acceptable fit to the cognitive data for both age groups,
with an average R2 of 0.92 and 0.84 for the young and old, respectively. Compliance with task
instructions was high, with 96% non-zero responses across the entire sample. Performance
increased across the retrieval blocks for all participants. Young adults performed better than their
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older counterparts as demonstrated by significant age differences in the asymptote: F (1,44) =
6.32, p = 0.015, Cohen’s d = 0.80, 95% CI for Cohen’s d: 0.16/1.45. Inflection point [F (1,44) =
1.15, p = 0.11] and slope [F (1, 44) = 0.14, p = 0.71] did not differ between the groups. However,
the effect size for inflection point (Cohen’s d = 0.34, 95% CI: -0.29/0.98) was greater than that
for the slope (Cohen’s d = 0.17, 95% CI: -0.51/0.75). There was no difference between men and
women for any of the Gompertz function parameters, nor was there any significant interaction
between sex and age group. Learning curves modeled using the Gompertz function as well as age
group differences in the three parameters are shown in Figure 10. Table 3 includes mean and
standard deviation values for the Gompertz function parameters.
Table 3. Gompertz function parameters for the two age groups (mean ± 1 standard error)
Gompertz function parameter

Old

Young

Asymptote (% correct)

84.98 ± 5.11

94.71 ± 1.29

Inflection Point (block number)

3.68 ± 0.52

3.18 ± 0.23

Learning Rate

0.43 ± 0.06

0.41 ± 0.03

There were no age differences in the free recall score obtained at the end of the entire
MRI scanning session (t < 1). However, within age groups, free-recall performance was
positively associated with the asymptote in old adults (Pearson’s r = 0.58, p = 0.028, F (1) =
14.36, p = 0.03) and negatively associated with the inflection point in the young adults
(Pearson’s r = - 0.42, p = 0.026, F (1) = 4.55, p < 0.012).
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A.

B.

C.

D.

Figure 10. Age differences in the associative learning and memory task. Gompertz function
modeled learning curves for both age groups (dashed line: old, solid line: young) (A), Mean age
group differences in asymptote (B), inflection-point (C), and learning-rate (D) (light gray: old,
dark gray: young). Error bars indicate ± 1 standard error. (* p < 0.05).
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4.3 1H fMRS results
4.3.1 Spectroscopy data quality check
Signal averaging of the acquired 1H MRS spectra into triplets (block triads) made of
consecutive encoding and retrieval blocks more than doubled the SNR from 4 ± 0.75 to 9.04 ±
1.65 but reduced the temporal resolution to about 96 seconds. Although the range of values of
LCModel fit characteristics (SNR, FWHM, and CRLB) across the entire sample was within
acceptable limits of data quality, younger adults demonstrated higher SNR and lower FWHM
and CRLB compared to the old (all p < 0.001), indicating better data quality. However, across
age groups and task stages the average SNR (9.26 ± 1.71), FWHM (8.27 Hz ± 1.78), CRLB
(8.08 ± 1.71) for glutamate were deemed optimal. LCModel fit characteristics averaged across
block triads per task stage for each age group are presented in Table 4. The abovementioned
LCModel indices did not differ significantly between the task stages for each age group, thus,
indicating an absence of bias due to differences in spectral quality between task stages.
Table 4. LCModel fit characteristics by task stage and age groups.
LCModel

fit

characteristic

Checkerboard

Encoding

Retrieval

Old

Young

Old

Young

Old

Young

SNR

8.8 ± 2

9.7 ± 1.4

8.6 ± 1.9

9.4 ± 1.3

8.5 ± 1.9

9.4 ± 1.4

FWHM (Hz)

8 ± 1.4

7.6 ± 1.6

8.8 ± 1.9

8 ± 1.8

8.9 ± 1.9

8.2 ± 1.9

8.7 ± 2.1

7.5 ± 1.2

8.8 ± 1.7

7.2 ± 1.1

8.8 ± 1.7

7.5 ± 1.3

CRLB (%)

Note: The values are mean ± 1 standard deviation. SNR = signal to noise ratio, FWHM =
fullwidth at half of maximum, CRLB = Cramér-Rao lower bound
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The average absolute concentration of glutamate across the entire task was 8.4 ± 1.19
mmol/kg, and that of glutamine was 2.97 ± 1.01 mmol/kg. The unilateral anterior hippocampal
voxel, in which 1H MRS signal was recorded, contained more gray matter by volume in the
young participants (60.5 ± 0.06%; range 46% to 74%) than in their older counterparts (45.2 ±
0.07%; range 33% to 60%); t (44) = 6.65, p < 0.000.
4.3.2 Age differences in steady-state hippocampal glutamate levels at the control condition
The levels of hippocampal glutamate during both task-free control conditions (fixation
cross and flashing checkerboard) did not differ between young and old participants (F < 1) and
there was no difference between the sexes (F < 1). The flashing checkerboard was chosen as the
control condition to be used in further analyses because of lesser variability in steady-state levels
of glutamate associated with this condition (Lynn et al., 2018). The glutamate levels under the
flashing checkerboard stimulation for each age group are illustrated in Figure 11. Unilateral
hippocampus (side randomized) was chosen since at the inception of the study there was no
hypothesis regarding the effect of hemispheric differences on hippocampal glutamate levels
during associative memory performance. However, a significant age group × side interaction [F
(1) = 7.89, p = 0.047] was noted for control-level glutamate, with older adults demonstrating
higher levels of glutamate in the left hippocampus compared to the right. No hemispheric
differences in control-level glutamate were observed in the young.
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Figure 11. Age differences in control-level
glutamate. (light gray: old, dark gray: young).
Error bars indicate ± 1 standard error.

4.3.3 Age differences in mean hippocampal glutamate levels during associative memory task
During memory encoding, young adults displayed higher levels of mean hippocampal
glutamate compared to their older counterparts: F (1, 182) = 8.36, p = 0.004, with a small to
medium effect size (Cohen’s d = 0.35, 95% CI: 0.15/0.68). In contrast, mean hippocampal
glutamate during memory retrieval did not differ between the age groups (F < 1) (Figure 12).
Within the young group, hippocampal glutamate levels during encoding showed a nonsignificant trend to exceed those during retrieval [F (1, 250) = 3.36, p = 0.07], with no task stage
dependent differences in the old group. There were no sex differences in mean glutamate levels
at any task stage. Mean levels of hippocampal glutamate for both age groups during the control
condition, encoding, and retrieval are presented in Table 5.
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Figure 12. Age differences in mean glutamate levels during
associative memory performance. Significant age differences in
hippocampal glutamate levels during memory encoding but not
retrieval (light gray: old, dark gray: young) (** p < 0.005).
Error bars indicate ± 1 standard error.

Table 5. Mean hippocampal glutamate levels (mmol/kg) for both age groups during the
control condition, encoding, and retrieval stages (mean ± 1 standard deviation).
Task stage

Old

Young

Checkerboard (control condition)

7.8 ± 1.5

7.7 ± 0.9

Memory Encoding

8.2 ± 1.3

8.8 ± 1.1

Memory Retrieval

8.3 ± 1.4

8.5 ± 1.1

In addition, for both age groups across both task stages, the main effect of side was significant [F
(1) = 12.7, p = 0.004]. The left hippocampus evinced higher mean glutamate levels during
encoding as well as retrieval across both age groups.

67
4.3.4 Age differences in hippocampal glutamate modulation during associative memory task
A repeated measure general linear model (GLM) analysis was conducted, with glutamate
levels as the dependent variable, age group, sex, and hippocampal side as categorical betweensubject variables, trial stage and block as within-subject (repeated) measures. Mean-centered
control level glutamate was the continuous covariate. The full model also included all first-order
interactions as well as the highest order age group × task stage × block triad interaction. A
reduced model was evaluated after the removal of non-significant interactions. Significant main
effects of age group [F (1, 308) = 7.39, p = 0.009, Cohen’s d = 0.87, 96% CI: 0.22/1.52],
hippocampal side [F (1, 308) = 5.01, p = 0.017, Cohen’s d = 0.72, 95% CI: 0.07/1.36], and
control-level glutamate [F (1, 308) = 26.19, p < 0.000], as well as significant age group × task
stage × block triad interactions [F (11, 308) = 2.48, p = 0.002] were noted. Young adults
demonstrated higher mean glutamate levels than the old. In both age groups, the left
hippocampus showed higher levels of glutamate throughout encoding and retrieval.
To assess whether the age group × block triad interaction was restricted to the encoding
stage as hypothesized, this interaction was explored by subsidiary GLM analyses conducted
separately for encoding and retrieval stages. A trend level age group × block triad interaction was
indicated for glutamate modulation during encoding [F (3, 132) = 2.41, p = 0.05] but not for
retrieval (F <1). In addition, this difference emerged during the second and last quarters of
encoding. Post hoc analyses showed that young adults demonstrated higher glutamate levels
compared to the old during the second (block numbers 4, 5, and 6) (Cohen’s d = 0.9, 95% CI:
0.25/1.56) and fourth (block numbers 10, 11, and 12) block triads (Cohen’s d = 0.43, 95% CI: 0.16/1.12) of encoding. Age differences for all retrieval block triads were non-significant (Figure
13).
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Figure 13. Age differences in glutamate modulation during associative memory
performance. Age differences in hippocampal glutamate modulation were specific to
memory encoding (dashed line: old, solid line: young). Post-hoc analysis revealed the
age differences to be significant in the second and fourth block-triads of memory
encoding. Within-group differences in glutamate levels between block triads are
indicated by hash sign (#). (* p < 0.05). Error bars indicate ± 1 standard error.

With respect to glutamate modulation within each age group; young adults demonstrated
differences in glutamate levels between the first and second (Cohen’s d = 0.34, 95% CI: 0.21/1.02), as well as the second and third (Cohen’s d = 0.58, 95% CI: -0.05/1.23) block triads of
encoding, and between the first and second (Cohen’s d = 0.46, 95% CI: -0.17/1.1) block triads of
retrieval (Figure 13). No such differences in mean glutamate levels across time were noted in the
elderly.
4.3.5 Relationship between glutamate levels and cognitive performance
Across both age groups, control-level glutamate did not explain associative memory
performance and was unrelated to any of the Gompertz function parameters. The effect of the

69
timing of glutamate response during encoding on performance was investigated. Old adults who
evinced maximum levels of glutamate (Glu-max) at a later block triad (block-max) during
encoding demonstrated non-significant trends towards a later inflection point [F (1, 42) = 3.61, p
= 0.06] (Figure 14 A) and a slower learning rate [F (1, 42) = 2.96, p = 0.09] (Figure 14 B).

Figure 14. Effect of glutamate modulation on memory performance. Old adults (red) with later
glutamate modulation showed a trend towards a later inflection point (A) and slower learning
rate (B). No effect of the timing of glutamate modulation was observed in the young (blue).

No such relationships were observed for young adults (blue line in Figure 14), nor did glutamate
levels obtained during retrieval show an association with the learning curve parameters in either
age group. In addition, Glutamate levels at any stage did not show an association with the free
recall score for either age group.
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4.3.6 Neurochemical specificity
With respect to age differences in the other 1H MRS-observable metabolites, old adults
had higher mean levels of PCr+Cr [F (1,42) = 4.32, p = 0.021], GPC+PC [F (1,42) = 14.36, p <
0.000], and myoinositol [F (1,42) = 9.68, p = 0.002] compared to the young. No age differences
were noted in NAA (F < 1). Importantly, for both age groups, the observed temporal effects
during encoding and retrieval were specific to glutamate, with no significant differences in levels
of the other metabolites at any block triad (supplementary figure S 1). GABA could not be
reliably measured since it is present at very low concentrations and special spectral editing
techniques are required to be able to resolve the GABA peak reliably.
4.3.7 BOLD effect
The BOLD effect that occurs due to increases in the concentration of oxygenated blood in
the task-active ROI reduces the spectral linewidth (i.e. FWHM) and affects signal amplitude.
Earlier 1H fMRS investigations have noted a significant BOLD effect as a function of task
(Mangia et al., 2007; Schaller et al., 2013). In the current study, for either age group, the FWHM
did not significantly differ across any task stage relative to the control condition (all F < 1).
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DISCUSSION
Episodic and associative memory impairment is one of the most common age-related
cognitive deficits and can be exacerbated in conditions such as Alzheimer’s disease (AD).
Glutamate, the primary excitatory neurotransmitter involved in cognitive processes, including
associative memory, is reduced in several key brain regions in AD (Butterfield & Pocernich,
2003) and in normal aging. Characterizing age effects on the modulation of glutamate in
response to a cognitive task has the potential of providing new insights on age differences in
neurotransmission-capacity related to cognitive decline. Proton functional magnetic resonance
spectroscopy (1H fMRS) is the only neuroimaging technique that can non-invasively measure
changes in levels (temporal modulation) of metabolites, in vivo, in response to functional
activation. Specifically, investigation of the temporal dynamics of neurotransmitter levels in
response to neuronal activation can shed light on the shift in the brain’s E/I balance that may be
dysregulated in aging and age-related neuropathology. The identification of altered dynamics of
task-related glutamate modulation in the elderly has the potential to provide an effective
framework to test better-targeted therapies to decelerate, if not reverse, the impending cognitive
decline.
The present study demonstrated, for the first time, the existence of age differences in
hippocampal glutamate modulation that may underlie those in associative memory performance,
with a specificity towards impaired associative encoding. As has been observed before in studies
of associative learning, older adults performed significantly worse than their younger
counterparts. Despite the absence of age differences in hippocampal glutamate levels during a
control condition, modulation of hippocampal glutamate during memory encoding was higher in
young adults compared to the old, in whom it was almost absent. Delays in glutamate elevation
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seemed to negatively affect older adults’ memory performance. In addition, the task-related
modulation was specific to glutamate, with no temporal changes observed in the levels of other
metabolites (NAA, GPC+PC, PCr+Cr, myoinositol). This neurochemical specificity of the
associative memory task with respect to glutamate is an important finding that ascertains the role
of glutamate in subserving memory performance as well as being sensitive to the different stages
of memory function. The main observations and the possible underlying mechanisms are
unpacked in the ensuing sections.
5.1 Interpretation of Results
5.1.1 Age differences in associative memory performance
Old adults demonstrated significantly lower asymptote than the young, indicating lower
associative memory proficiency. A non-significant later inflection point among the elderly may
suggest a possible delay in the acquisition and consolidation of memory for the object-location
associations. This is in line with the ADH (Naveh-Benjamin, 2000), which posits that older
adults are disproportionately deficient in tasks of associative memory. The ADH is based on
observations that although their memory for individual items might be unimpaired, older adults
perform worse than the young on tests of associative memory that require the creation and
retrieval of links between the associated memoranda. Indeed, the free-recall test administered
after the scanning session showed no age differences indicating similar item memory in the
young and old. Among the old adults, those who demonstrated proficient associative memory
inside the scanner performed better on the free recall test. Young adults who demonstrated an
earlier inflection point (i.e. an earlier transition from presumably less consolidated to more
consolidated learning) during in-scanner performance, scored higher on the free recall test.
In addition to the biological age effects, it is important to consider certain aspects of the
study design that may underlie the observed age differences. This study differed from the Stanley
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et al study, in that, the resting condition that would have allowed memory rehearsal was replaced
by a backward-counting task. This task was included to intentionally suppress the articulatory
loop and block memory rehearsal, specifically the individual variability that comes with it.
However, interference in memory rehearsal that takes place during the rest period may result in
disruption of memory consolidation (Ravishankar et al., 2019). An age-related difficulty in
retaining the object-location associations in the absence of rehearsal may have contributed to the
older adults’ weaker performance noted here (Gick, Craik, & Morris, 1988). It has been shown
using the older version of the object-location task (Diwadkar et al., 2008), that during the rest
period the functional connectivity between regions involved in associative learning gradually
changes as proficiency on the task increases (Ravishankar et al., 2019). Although lack of an
opportunity to rehearse can plausibly underlie age differences in associative memory, one study
has demonstrated absence of age differences in the articulatory loop processing (using digit-span
and word-span tasks) (Fisk & Warr, 1996) that is required for rehearsal. If this holds true, it is
possible that the age differences in associative memory seen in the current study are true
differences therein.
Another factor that may have affected performance on the task was time to recall. It is
possible that the time (2.67 seconds) provided for encoding as well as recalling an object in the
cued location was insufficient for the old adults and might have taxed their processing capacities,
thus, penalizing them on memory performance. Studies on associative learning have
demonstrated that older adults’ poorer performance is related to inefficient memory encoding,
which in turn may be explained by deficiencies in processing speed. In fact, about 50 to almost
100% of age-related variance in associative learning is shared with processing speed (Salthouse,
1994, 1996). Slower processing speed results in weaker encoding of an association, the
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representation of which is labile and may be susceptible to interference by processing of the
immediate next association. A stable representation allows more information to be retained,
whilst new is being acquired. Thus, even though 12 rounds of encoding and retrieval were
presented to each participant to allow strengthening of the associations, weak representations of
the associations may have resulted in delayed strengthening thereof, and hence a later inflection
point in the elderly. The possibility that processing speed may have been a factor was also
surmised from the feedback on task-speed received from the participants after the scanning
session. For some participants, performance on the exploratory free-recall paper-pencil test given
post-scan was better than in-scanner performance. Since this test did not impose any time limit it
can be assumed that task-speed may have contributed to weaker in-scanner performance for
some individuals. However, on the other hand, it cannot be denied that 12 trials, instead of a
single presentation of the object-location associations inside the scanner may have resulted in
better free recall performance.
5.1.2 Evidence of age differences in glutamate modulation during associative memory
performance, despite none in steady-state control-level glutamate
In the current study, no age differences were observed in control levels of hippocampal
glutamate. Previous studies have documented age differences in glutamate levels, albeit in
different ROIs (motor cortex, basal ganglia) (Hädel et al., 2013; Kaiser et al., 2005; McEntee &
Crook, 1993; Sailasuta, Ernst, & Chang, 2008). In those studies, age effects were noted in NAA
levels as well, with a positive relation between glutamate and NAA. NAA is a putative neuronal
marker and thus, lower glutamate and NAA were attributed to age-related neuronal loss.
However, there is no wide-spread neuronal loss in normal aging (Morrison & Hof, 1997;
Yankner et al., 2008). Accordingly, along with a lack of age differences in glutamate, the current
study did not observe differences in levels of NAA either. It is also important to remember that

75
the exclusion criteria imposed in the current study (see Chapter 3, participants section) are more
stringent than most other groups use. This reflects the selection of a very healthy group of old
adults, and so a lack of age differences in control levels of glutamate can be expected.
Hemispheric differences were noted only in the old adults, where glutamate levels were higher in
the left compared to the right hippocampus.
During the associative memory task, significant age differences in hippocampal
glutamate modulation emerged and were specific to the encoding stage. During encoding, the
young adults evinced higher and earlier glutamate modulation, levels of which returned to initial
values with a non-significant rise towards the end. The initial increase in glutamate during
retrieval in this group, stabilized later. Glutamate modulation during encoding and retrieval was
non-significant to almost absent in the elderly, as confirmed by a lack of differences in glutamate
levels between the block triads within each memory stage. The initial ramp-up of glutamate in
the young suggests that there is rapid deployment of a glutamate-driven process that dissipates
once a stable performance level (probably due to better and earlier memory consolidation) is
reached. This can be explained by the following two scenarios.
5.1.2.1 Reduced neuro-metabolism and neurotransmission in the elderly
The demands of encoding might have driven an increase in hippocampal excitatory neural
activity that was indicated by glutamate elevation. Task-induced surges in glutamate possibly
reflect increases in glutamate synthesis and glutamatergic neurotransmission as well as glucose
utilization and oxidative metabolism in the regions responsive to the specific task-related
stimulation. Owing to the large voxel that contains intra- and extracellular space, the 1H fMRS
signal cannot distinguish between the compartment (intracellular versus extracellular) and the
cell type (glia versus neurons) that glutamate is being measured from. In addition, glutamate
signal arising from neurotransmission and metabolic processes cannot be separated. Hence, the
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task-related increase in glutamate captured by the 1H fMRS signal indicates higher net formation
of glutamate reflecting increased excitatory neurotransmission and oxidative metabolism to meet
the energy demand of higher neuronal activity. This has been a consensus among extant 1H
fMRS literature, since, a tight coupling has been demonstrated between the glutamate
neurotransmitter cycling and the rate of glucose oxidation (De Graaf, Mason, Patel, Rothman, &
Behar, 2004; Rothman et al., 2011; Sibson et al., 1998; Sonnay, Duarte, Just, & Gruetter, 2016).
Therefore, the task-related changes in glutamate, as detected by 1H fMRS, probably reflect
increased metabolism as well as excitatory neurotransmission in the young in response to
associative encoding. This indicates the attainment of a new metabolic steady state reflecting the
neural response leading to shifts in the local E/I balance. On the other hand, an absence of
apparent glutamate modulation in the elderly may signal age-associated decrease in metabolism,
neurotransmission, or a combination of both.
A recently published study (Crofts, Trotman-Lucas, Janus, Kelly, & Gibson, 2020)
demonstrated significant reduction in glutamate modulation during sensory forepaw stimulation
in aged rodents. The authors hypothesized that age-related impairment in the glutamateglutamine cycle in these animals might have affected further glutamate release, thus leading to a
net decrease in glutamate levels. About a 30% age-associated reduction in the rate of the
neuronal TCA cycle as well as the glutamate-glutamine cycle have been documented
(Boumezbeur et al., 2010). Age-related glucose hypometabolism may also play a role here.
Under non-fasting conditions, the brain depends nearly entirely on glucose as its main substrate
for energy production. The mitochondrial metabolism of glucose via the TCA cycle is the
primary source of this energy (ATP). Mitochondrial dysfunction that occurs with aging (Raz &
Daugherty, 2018) can underlie impairment in glucose metabolism and disrupt energy supply in
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the brain. Importantly, levels and rates of cerebral glucose metabolism in the hippocampus have
been shown to predict gradual decline from normal cognition to AD (Lin & Rothman, 2014;
Mosconi, 2005).
5.1.2.2 The effects of age on the constituents of the synapse
There is a constellation of molecular mechanisms transpiring at the synapse that drives
shifts in E/I balance in response to neural stimulation. It is possible that an age-related
impairment in any of these mechanisms (elucidated below) could lead to a dysfunction in the
ability to modulate the E/I equilibrium, thus affecting functioning.
Age-related reduction in the density and binding efficiency of the glutamatergic NMDA
receptors (Magnusson et al., 2010), glutamate transporters, or even lower depolarization-induced
release of glutamate during LTP (Lynch, 2004) can affect glutamate modulation individually or
in concert. Decline in the number of NMDA receptors in the hippocampus and the cortex has
been documented in several species and seems to be the most robust effect of age at the synapse.
Spatial memory deficits in aging rodents have been associated with impaired NMDA receptor
function as well (Menard et al., 2015). Western blot analyses of synaptic excitatory and
inhibitory proteins in aged monkeys has shown a reduction in NMDA as well as GABA(a)
receptor subunits suggesting an age-related effect on both components of the E/I machinery
(Williams, Pinto, Irwin, Jones, & Murphy, 2009). Imbalances in the receptors and decreased
post-synaptic density in prefrontal cortices of aged rodents (Majdi, Ribeiro-da-Silva, & Cuello,
2009), and reduced excitation and increased inhibition in prefrontal cortices of aged monkeys
(Luebke, Chang, Moore, & Rosene, 2004) have also been documented. Like in the prefrontal
cortex, similar effects of aging are possible at the hippocampal synapses as well. Reduced levels
of stimulated glutamate release and of vGLUT proteins have been documented in AD-type and
aged wild-type rodents (Minkeviciene et al., 2008). Diminished in vivo glutamate release in aged
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rats (Stephens, Quintero, Pomerleau, Huettl, & Gerhardt, 2011), as well as from hippocampal
slice preparations of aged rats (review by (Segovia, Porras, Del Arco, & Mora, 2001)) support
the possibility of age-effects on vGLUT function that may affect vesicular glutamate packaging
and subsequent glutamate release.
As suggested in Figure 15, the synapse affords several target mechanisms that underlie
the observed age-related absence of glutamate modulation as measured by 1H fMRS in the
current study. These mechanisms include, but are not limited to, age-related loss of the entire
synapse, impaired NMDA receptor density and kinetics, reduced levels of vGLUT, weakened
release of pre-synaptic glutamate, and mitochondrial dysfunction as reflected by impaired TCA
cycle (Yankner et al., 2008).

Figure 15. Effects of age on the glutamate-glutamine cycle. Adapted from Figure 1 of this
dissertation, this simplified cartoon illustrates the hotspots (marked by bold red ‘T’) at the
synapse that are some of the targets of aging and can individually or in concert impair the
glutamate-glutamine cycle leading to weaker glutamate modulation in the elderly.
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Indeed, it can be appreciated that the synapse is an inherently complex environment affording
several targets for the effects of age to manifest themselves on, and possibly contribute to the
nature of the glutamate signal as measured by 1H fMRS.
In the current study, although glutamine levels could not be reliably measured (owing to
its low SNR and high CRLB values), an exploratory assessment indicated that in the elderly,
glutamine evinced a pattern complementary to glutamate specifically during encoding
(supplementary figure S 2). Similar age-related decrease in glutamate but increase in glutamine –
although in different ROIs, was also noted by Kaiser et al (Kaiser et al., 2005). Glutamine is a
precursor to glutamate. A possible increase in glutamine at the expense of glutamate modulation
in the elderly might suggest age-related dysfunction of the glutamate-glutamine cycle
(Boumezbeur et al., 2010). Increases in glutamine could also be due to reduced glutaminase
activity (reduced breakdown of glutamine), or due to NMDA receptor hypofunction that has
been shown to potentiate glutamine synthetase activity (increased formation of glutamine) (Jelen,
King, Mullins, & Stone, 2018).
5.1.3 Glutamate modulation and associative memory performance
The present study provides the first evidence of age differences in hippocampal glutamate
modulation specifically during associative encoding (Figure 13). Notably, the timing of
glutamate modulation, indicated by the block triad (‘block-max’) at which glutamate levels were
the highest during encoding (‘Glu-max’), may be related to older adults’ associative memory
performance. Older adults who demonstrated a delayed rise in glutamate levels demonstrated a
trend to suffer a later inflection point and a slower learning rate with no effect on their
asymptote. This may indicate that early elevation in glutamate in response to memory encoding
may play a more important role in enabling faster acquisition of memories rather than affecting
the final memory capacity (i.e. the asymptote). Early glutamate increase plausibly reflects early
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hippocampal engagement during memory encoding, since initially in the process of learning the
hippocampus is assumed to be rapidly engaged in acquiring new associations. Interestingly, a
coincidence was noted between possible age differences in the inflection point around the second
block triad (combination of blocks 4, 5, and 6) (see Table 3) and those in glutamate modulation
also around the same time point (see Figure 13). This further points to the possibility that earlier
and higher glutamate modulation in the young may underlie better associative memory function.
Owing to the low sample size and high variability in the learning curve parameters in the group
of old adults, the data on the effect of block-max demonstrate trend-level effects.
As mentioned in Chapter 1, LTP is the cellular mechanism of information storage and
memory encoding. Two steps in the process of LTP are crucial – induction and maintenance.
Hippocampal LTP induction depends on glutamate-mediated activation of post-synaptic NMDA
receptors. It has been speculated that maintenance of LTP might be supported by the persistent
enhancement of glutamate release (Richter-Levin, Canevari, & Bliss, 1995). Remember that this
persistent increase in glutamate release is assumed to be accompanied by shifts in neuronal
circuitry to maintain the E/I balance, as well as efficient extra-synaptic glutamate clearance to
prevent excitotoxicity. Assuming this possibility, the early increase in encoding-related
glutamate in the young participants, followed by a return to and stabilization around initial
levels, may reflect LTP maintenance subserving memory consolidation and better associative
memory performance. Lack of glutamate increase in the elderly indicates a possible dysfunction
in the LTP induction as well as maintenance mechanisms.
A critical feature of cognitive biomarker studies is indeed the elucidation of the
relationship between the biomarker and cognitive function. Previous studies that have reported
associations between brain glutamate levels and cognitive performance, have done so by
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correlating out-of-scanner performance with static levels of glutamate measured in specific ROIs
using 1H MRS (Nikolova et al., 2017; Thielen et al., 2018). However, such correlations fail to
unveil the neurotransmitter dynamics during cognitive functioning that may be central for
comprehending the finer mechanisms of memory dysfunction. In contrast to those reports, the
current study did not detect any effect of control-level hippocampal glutamate on the out-ofscanner free recall test for either age group, and nor was control-level hippocampal glutamate
related to any of the in-scanner learning curve parameters.
The advent of functional 1H MRS (1H fMRS) has made it possible to track changes in
neurotransmitters in real time during neuronal stimulation. Indeed, this technique has been
successfully applied in younger adults and patients with schizophrenia to investigate glutamate
dynamics in the dorsolateral prefrontal cortex during working memory performance (Woodcock
et al., 2018), and in the hippocampus during object-location association memory formation (J.A.
Stanley et al., 2017). The latter study demonstrated the existence of unique temporal dynamics of
glutamate during encoding in fast and slow young learners and indicated that the timing of
glutamate modulation during encoding may matter for the acquisition of object-location
associations. Brain-behavior relationships can be complicated to model as they operate on
different scales. Statistically elucidating such relationships becomes an intriguing challenge since
a cognitive behavioral outcome mostly follows an established model, whereas the behavior of the
biomarker is a biological and molecular process possibly driven by feedback and thresholds.
Increase in neuronal activity during learning results in increased glutamate synthesis and cycling
that is manifested as an increased glutamate signal in 1H fMRS. Thus, a linear relation between
glutamate levels and memory score seems like a possibility – but up to a certain threshold.
Although an increase in glutamate following neuronal stimulation is an optimum response, a
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persistent increase may signal inefficiency of the neuronal ensemble. Instead, feedback from the
glutamatergic system and well as an adjustment to the E/I equilibrium makes sense, where, as
learning approaches an asymptote, glutamate levels stop rising and instead reduce to initial
levels. The attainment of asymptotic performance during learning and memory mostly indicates
successful memory consolidation without further need to be supported by increases in glutamate.
The current study was based on the hypothesis that age differences in glutamate
modulation would be specific to associative encoding. Although extant literature has emphasized
deficits in binding during encoding as the underlying factor in associative memory impairment,
deficits related to the retrieval process are possible as well. The approach applied in the current
study, in fact, allows investigation of individual task stages (encoding or retrieval) where
functional impairments indeed may lie.
This study did not hypothesize hemispheric effects on hippocampal glutamate levels
during associative memory performance owing to the nature of the task that involved
vocalization of the object-location pairs during encoding and retrieval. The task thus probed
spatial, visual, as well as verbal memory, characterized by differential involvement of the left
and right hippocampi. Therefore, 1H MRS voxels were placed in unilateral hippocampi with side
randomized across participants. However, higher levels of glutamate in the left hippocampus
were observed throughout the encoding and retrieval stages in both age groups. It is possible that
higher left-lateralized hippocampal activation occurred due to the verbal nature of encoding and
retrieval in the current associative memory task, characterized by a vocal response. A few studies
have demonstrated stimulus-specific hemispheric specialization of the hippocampus, with the
right and left hippocampi being involved in spatial (or non-verbal) and verbal memory encoding,
respectively (Ezzati et al., 2016; Kelley et al., 1998).

83
5.2 Study Limitations
The findings reported here should be interpreted in the light of the limitations in study
design and sampling. First, it is a cross-sectional study investigating two intentionally chosen
healthy and extreme age groups (young: 21 to 30 years and old: 60 to 70 years), and like any
cross-sectional study it cannot speak to true age-related change and individual differences therein
(Raz & Lindenberger, 2011). Although these data demonstrate interesting trends, the small and
unbalanced sample size precludes definite results. It is thus, necessary to recruit additional older
adults and continue with data collection, to be able to confirm the observed trends.
Second, with respect to study design, all MRI scans were collected between 9:00 am and
noon to keep time of scanning constant. However, this constraint might have failed to capture
some participants’ performance during their best time of the day (Maylor & Badham, 2018). In
addition, no information was collected about participants’ sleep quality the night before as well
as caffeine-intake status – variables which may affect attention and hence, memory performance,
thus adding to individual variability. The objects and cues during memory encoding and retrieval
were presented for a very short time (2.67 sec). Thus, in the absence of rehearsal, taskpresentation speed may have taxed the processing speed capacities of some participants,
affecting their memory performance. Older adults’ poorer performance on the task may in fact be
related to slower processing speed (Park et al., 1996; Salthouse, 1994, 1996) rather than weaker
memory function. Age differences in processing speed were not measured and thus, its effect on
associative memory performance could not be assessed here. Other cognitive domains that were
not measured but can affect associative memory performance are attention, working memory
capacity, and inhibitory processing (Spencer & Raz, 1995).
Third, with respect to the technique, the large voxel used in this study may induce
possible partial volume effects that are common in single-voxel MRS studies. However, the
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influence of partial volume effects on the findings were minimized by ensuring individualized
placement of the hippocampal voxel and including only within-subject analyses across
conditions during the assessment of temporal modulation of glutamate. Being a single-voxel
study, the technique also precluded measuring and comparing metabolites from a control area of
the brain not involved in associative learning and memory function. In addition, associative
memory function depends on the fronto-hippocampal network (Simons & Spiers, 2003) with
support from other cortical regions; and thus, poor performance on associative tasks may be
related to the impaired functioning of these regions as well. Since single voxel 1H fMRS
precludes the investigation of other ROIs, future multivoxel MRS studies will help augment our
understanding of the entire system involved in successful encoding and retrieval.
Finally, owing to a lower field strength (3T) this study lacked the ability to reliably
quantify other relevant molecules such as GABA, glutamine, or lactate. It is important that future
studies quantify these metabolites, along with glutamate, since neurotransmission and
neurometabolism function via an interplay between these metabolites.
5.3 Future Directions
This dissertation is only the first step towards probing and understanding age differences
in task-related glutamatergic modulation that might serve as a plausible biomarker of cognitive
deficit. The findings in this study open up several exciting avenues for future investigations.
First, the observed age differences in glutamate modulation during associative memory
function should be confirmed with tasks using different stimuli such as word-pairs and facesnames that have been described in extant literature on age-related associative deficits (Bender et
al., 2017; Naveh-Benjamin, 2000). The results of this cross-sectional investigation should be
further leveraged in developing a long-term follow-up study to examine the utility of variations
in task-related glutamate modulation as an early biomarker of cognitive decline, and possibly be
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later extended to include participants with mild cognitive impairment and AD. The etiology and
pathophysiology of AD being complex, non-invasive investigations of age effects on
neurotransmission can contribute towards the identification of early diagnostic biomarkers of
AD. This is a crucial aspect of AD research especially for implementing timely interventions at
the preclinical stages of the disease.
Associative learning is subserved by the fronto-hippocampal circuitry and the different
stages of memory function can activate these regions differentially. During encoding and
retrieval, there is an interplay between other cognitive domains such as attention and inhibition
that call upon other brain regions. Future studies should involve a multivoxel, multi-ROI
investigation of the temporal dynamics of glutamate during encoding and retrieval.
The current investigation informs on changes in net glutamate levels i.e. a combination of
intracellular, extracellular, neuronal, and glial stores of glutamate. At the molecular level the
observed age differences can be explained by a myriad of possible underlying mechanisms, such
as age-related reduction in the number and binding efficiency of NMDA receptors (Magnusson
et al., 2010) and transporters (Minkeviciene et al., 2008), and a reduction vesicular release of
glutamate (Lynch, 2004) (as also outlined in Figure 15). Future analyses can, thus, include
genomics and proteomics to assess the different players that glutamate levels depend on. Testing
participants for polymorphisms of the genes coding for NMDA receptors and glutamate
transporters can also shed light on finer details of glutamatergic function.
5.3.1 Possible therapeutic targets in the glutamatergic system
An understanding of glutamatergic dysfunction underlying cognitive deficits may pave
way to design therapeutic and interventional approaches. Considering the numerous players
involved at the synapse and in the glutamatergic system, interventional research has been
directed towards targeting any one or a combination of them. In addition to direct genetic
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manipulation, pharmacological drugs targeting the glutamatergic systems are also being tested
and developed. For instance, NMDA receptor function can be elevated by application of its
exogenous agonists. Although L-glutamate, an agonist, has not been suggested because of the
risk of excitotoxicity, D-cycloserine, a partial agonist at the glycine binding site of the NMDA
receptor has indeed shown to elevate the receptor’s function only till its maximum physiological
capacity, thus avoiding neurotoxicity (Jones, Wesnes, & Kirby, 1991). Partial modulation of the
NMDA receptor by D-cycloserine has shown improved spatial memory in aged rats
(Dauvermann, Lee, & Dawson, 2017). Although partial agonists of the NMDA receptor have
demonstrated positive effects in humans (Müller, Scheuer, et al., 1994), conclusive evidence of
the benefits of such agents in human cognition is still lacking and more research in this direction
is necessary.
5.4 Conclusions
This study demonstrates, for first time, existence of age differences in hippocampal
glutamate modulation during associative memory function and their specificity to associative
encoding. This phenomenon may underlie the observed age differences in the performance of the
associative memory task. The modulation of hippocampal glutamate in response to memory
function can be construed as the result of increased metabolic demand and excitatory
neurotransmission required by the processes of encoding, accompanied by a shift in the brain’s
E/I balance to serve the task demands. The observed absence of glutamate modulation in the
elderly is endorsed by their deficits in associative encoding as well as by a possible age-related
reduction in brain energy regulation and neurotransmission, as well as possible age effects on
maintaining the E/I equilibrium. Hippocampal atrophy, a part of normal as well as pathological
aging, is not a reliable biomarker of the earlier stages of impending dementia. Thus,
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identification of a functional biomarker of cognitive performance is necessary, and investigation
of age differences in task-related glutamate modulation may contribute towards it.
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Supplementary figures

S 1. Neurochemical Specificity. Levels of other main metabolites detected by 1H MRS. NAA,
PCr+Cr, GPC+PC, and myoinositol did not show temporal modulation across encoding and
retrieval in both age groups (dashed line: old, solid line: young). The numbers on the Y axis are
overall mean levels of these metabolites after collapsing across age groups and the two task
stages. Error bars indicate ± 1 standard error.
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S 2. Age differences in glutamine levels across encoding and retrieval (dashed line: old, solid
line: young). Error bars indicate ± 1 standard error.
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ABSTRACT
AGE DIFFERENCES IN HIPPOCAMPAL GLUTAMATE MODULATION DURING
ASSOCIATIVE LEARNING AND MEMORY: A PROTON FUNCTIONAL MAGNETIC
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Degree: Doctor of Philosophy
Episodic and associative memory decline is one of the earliest cognitive impairments in
normal aging and among the defining cognitive features of Alzheimer’s disease (AD). Since,
age-related cognitive decline gradually devolves into AD, with neuropathology preceding
cognitive changes by many years, the identification of biomarkers of early disease progression is
crucial. Reduction in glutamate, the main excitatory neurotransmitter involved in associative
memory, in key brain regions such as the hippocampus, has been theorized as one of the cellular
mechanisms underlying cognitive decline in aging and AD. A few neuroimaging studies that
demonstrated a link between older adults’ weaker cognitive performance and lower hippocampal
glutamate levels, correlated static levels of glutamate with out-of-scanner performance. The
current study is the first to investigate age effects on temporal modulation of hippocampal
glutamate during associative memory performance. Proton functional magnetic resonance
spectroscopy (1H fMRS) was used to examine hippocampal glutamate modulation in healthy
young and old adults during associative memory performance. Proton spectra from unilateral
hippocampi were acquired during task performance and during a preceding non-task-active
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control condition. Young adults demonstrated better associative memory performance than the
old. Despite no age differences in glutamate levels during the control condition, significant age
differences were detected in the temporal modulation of glutamate during the associative
memory task that were specific to memory encoding. Young adults evinced higher glutamate
levels earlier during encoding, that later reduced when the capacity to encode had presumably
approached saturation. Conversely, old adults failed to demonstrate significant glutamate
modulation in either memory stage. However, within the older group, associative memory
performance seemed to depend on the timing of glutamate elevation during encoding.
Specifically, old adults who displayed earlier glutamate elevation demonstrated a trend towards a
later inflection point and a slower rate of learning. These results indicate that early glutamatergic
response during memory encoding reflects early engagement of the hippocampus leading to
better associative memory performance. This study provides the first in vivo demonstration of
age differences in hippocampal glutamate modulation during associative memory performance
and is the first step towards better elucidation of glutamatergic contribution to age-related
cognitive differences.
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